*type	project_id	*submitter_id	cases.submitter_id	demographics.submitter_id	*days_to_follow_up	admission_date	ascites_culture	ascites_culture_result	ascites_date	ascites_diagnosis_date	ascites_organism	bariatric_surgery	blood_culture	blood_culture_date	blood_culture_result	blood_organism	bmi	cdc_hiv_risk_factors	child_pugh_score	ct_date	ct_result	ct_result_finding	ct_result_sig	duodenum_ulcer_bleed	duodenum_ulcer_size	endoscopy	endoscopy_date	endoscopy_ulcer_present	endoscopy_varices_present	esophageal_ulcer_bleed	esophageal_ulcer_size	esophageal_varices_bleed	esophageal_varices_size	event_type	fibro_capmed	fibro_e	fibro_iqr	fibro_probe	fibro_total_number	fibroscan	fibroscan_date	firbro_e_iqr	firbro_valid_number	gastric_ulcer_bleed	gastric_ulcer_size	gastric_varices_bleed	gastric_varices_size	height	hep_carcinoma	hep_enceph	hep_enceph_diagnosis_date	hepcar_diagnosis_date	hospitalized_alc_hep	hospitalized_alc_hep_times	hospitalized_at_enrollment	infection_screen_date	infection_screen_done	lille_score	liver_abdomen_imaging	liver_imaging_type	liver_score_collected	liver_score_date	liver_transplant	liver_transplant_date	maddreys_score	medical_info_collected	meld_score	mri_date	mri_finding	mri_result	mri_sig	other_imaging_date	other_imaging_finding	other_imaging_result	other_imaging_sig	other_imaging_type	portal_hypertensive_gastropathy	soc_collected	stool_test	stool_test_date	stool_test_finding	tlfb_collected	tlfb_drinking_days	tlfb_number_drinks	ultrasound_date	ultrasound_finding	ultrasound_result	ultrasound_result_sig	urine_culture	urine_culture_date	urine_culture_fungal_result	urine_culture_organism	urine_culture_result	varices	varices_diagnosis_date	visit_day	weight	xray	xray_date	xray_findings	xray_impression	xray_infiltrates	xray_last_4_weeks	xray_normal	xray_pleural_effusion	usubjid	brthdtc
follow_up	ARDaC-AlcHepNet	11055_clinical_0	11055_clinical	11055_clinical_demographic	0		Not Done							12828	Negative		29		8							No																														12828	Yes					12829					21																13	106					Not Done							0	105.2									11055	1985-09-04
follow_up	ARDaC-AlcHepNet	11055_clinical_3	11055_clinical	11055_clinical_demographic	3		Not Done							12828	Negative		29.4									Yes				No	Large	No	Small																							12828	Yes					12830															Missing												Not Done							3	106.6									11055	1985-09-04
follow_up	ARDaC-AlcHepNet	11055_clinical_7	11055_clinical	11055_clinical_demographic	7																																																									12836					21																													7										11055	1985-09-04
follow_up	ARDaC-AlcHepNet	11055_clinical_14	11055_clinical	11055_clinical_demographic	14																																																																														3	24												14										11055	1985-09-04
follow_up	ARDaC-AlcHepNet	11055_clinical_28	11055_clinical	11055_clinical_demographic	28		Not Done							12828	Negative		31		9							Yes				No	Large	No	Small																							12828	Yes					12857					19										Missing						0	0					Not Done							28	112.6									11055	1985-09-04
follow_up	ARDaC-AlcHepNet	11055_clinical_60	11055_clinical	11055_clinical_demographic	60																																																																														1	7												60										11055	1985-09-04
follow_up	ARDaC-AlcHepNet	11055_clinical_90	11055_clinical	11055_clinical_demographic	90												29.5									No																															No					12920																					30	137												90	107.1									11055	1985-09-04
follow_up	ARDaC-AlcHepNet	11055_clinical_180	11055_clinical	11055_clinical_demographic	180												27.4		6							No																															No					13008					11																27	65												180	99.3									11055	1985-09-04
follow_up	ARDaC-AlcHepNet	11058_clinical_0	11058_clinical	11058_clinical_demographic	0												28.1		9							Yes																															No					10625					24										Missing						0	0												0	71.9									11058	1991-10-23
follow_up	ARDaC-AlcHepNet	11058_clinical_3	11058_clinical	11058_clinical_demographic	3												31.5		9																																											10626					24																													3	80.9									11058	1991-10-23
follow_up	ARDaC-AlcHepNet	11058_clinical_7	11058_clinical	11058_clinical_demographic	7												30.7		8																																											10632					23																													7	78.6									11058	1991-10-23
follow_up	ARDaC-AlcHepNet	11058_clinical_14	11058_clinical	11058_clinical_demographic	14												27.7		8																																											10639					23																0	0												14	70.9									11058	1991-10-23
follow_up	ARDaC-AlcHepNet	11058_clinical_28	11058_clinical	11058_clinical_demographic	28		Not Done							10641	Negative				9							No																														10641	Yes					10648					26																0	0						10643			Negative			28										11058	1991-10-23
follow_up	ARDaC-AlcHepNet	11066_clinical_0	11066_clinical	11066_clinical_demographic	0			Negative	9681				No				30.5		11							Yes	9683					Missing	Small																							9681	Yes					9683					26										Yes, Mild						0	0					Not Done							0	99.2									11066	1994-07-03
follow_up	ARDaC-AlcHepNet	11066_clinical_3	11066_clinical	11066_clinical_demographic	3		Not Done							9683	Negative		30.4		11							No																														9683	Yes					9685					26																						Not Done							3	98.9									11066	1994-07-03
follow_up	ARDaC-AlcHepNet	11066_clinical_7	11066_clinical	11066_clinical_demographic	7												25.3		10							No																															No					9692					23																													7	82.2									11066	1994-07-03
follow_up	ARDaC-AlcHepNet	11066_clinical_14	11066_clinical	11066_clinical_demographic	14												24.1		10							No																															No					9697					21																0	0												14	78.3									11066	1994-07-03
follow_up	ARDaC-AlcHepNet	11066_clinical_28	11066_clinical	11066_clinical_demographic	28												18.9		8							No																															No					9712					19																0	0												28	61.6									11066	1994-07-03
follow_up	ARDaC-AlcHepNet	11066_clinical_60	11066_clinical	11066_clinical_demographic	60												20.1		8							No																															No					9740					17																0	0												60	65.4									11066	1994-07-03
follow_up	ARDaC-AlcHepNet	11066_clinical_90	11066_clinical	11066_clinical_demographic	90												20.9		8							No																															No					9766					16																0	0												90	67.8									11066	1994-07-03
follow_up	ARDaC-AlcHepNet	11066_clinical_180	11066_clinical	11066_clinical_demographic	180												21		7							No																															No					9857					15																0	0												180	68.2									11066	1994-07-03
follow_up	ARDaC-AlcHepNet	11067_clinical_0	11067_clinical	11067_clinical_demographic	0												22		10							Yes						Missing	Medium																								No					17595					21										Yes, Moderate						26	203												0	63.7									11067	1972-11-17
follow_up	ARDaC-AlcHepNet	11067_clinical_3	11067_clinical	11067_clinical_demographic	3												22		9							No																															No					17598					19																													3	63.7									11067	1972-11-17
follow_up	ARDaC-AlcHepNet	11067_clinical_7	11067_clinical	11067_clinical_demographic	7												21.8		11							No																															No					17602					20																													7	63.2									11067	1972-11-17
follow_up	ARDaC-AlcHepNet	11067_clinical_14	11067_clinical	11067_clinical_demographic	14												22.5		11							No																															No					17609					35																13	105												14	65.3									11067	1972-11-17
follow_up	ARDaC-AlcHepNet	11067_clinical_28	11067_clinical	11067_clinical_demographic	28			Positive	17622		Klebsiella pneumoniae			17622	Positive	Klebsiella pneumoniae	19.8		12							Yes						No	Medium																							17622	Yes					17624					37										Yes, Moderate						0	0					Not Done							28	57.4									11067	1972-11-17
follow_up	ARDaC-AlcHepNet	11071_clinical_0	11071_clinical	11071_clinical_demographic	0												31.3		9							No																															No					15726					34																													0	98.9									11071	1978-01-26
follow_up	ARDaC-AlcHepNet	11071_clinical_3	11071_clinical	11071_clinical_demographic	3		Not Done							15728	Negative		31.3		11							No																														15728	Yes					15729					34																						Not Done							3	98.8									11071	1978-01-26
follow_up	ARDaC-AlcHepNet	11071_clinical_7	11071_clinical	11071_clinical_demographic	7		Not Done							15733	Negative		32		11							No																														15733	Yes					15733					40																							15733	Yes	Candida albicans	Positive			7	101.1									11071	1978-01-26
follow_up	ARDaC-AlcHepNet	11071_clinical_14	11071_clinical	11071_clinical_demographic	14			Negative	15737					15740	Negative		34.4									No																														15737	Yes					15740					42																						Not Done							14	108.6									11071	1978-01-26
follow_up	ARDaC-AlcHepNet	11078_clinical_0	11078_clinical	11078_clinical_demographic	0												35.1		11							No																															No					16065					24																0	0												0	89.8									11078	1977-04-05
follow_up	ARDaC-AlcHepNet	11078_clinical_3	11078_clinical	11078_clinical_demographic	3		Not Done							16067	Negative		35.1		10							No																														16067	Yes					16068					31																						Not Done							3	89.8									11078	1977-04-05
follow_up	ARDaC-AlcHepNet	11078_clinical_14	11078_clinical	11078_clinical_demographic	14			Negative	16080					16071	Negative				11							No																														16069	Yes					16080					36																							16069	Yes	Candida albicans	Positive			14										11078	1977-04-05
follow_up	ARDaC-AlcHepNet	11080_clinical_0	11080_clinical	11080_clinical_demographic	0		Not Done							19327	Negative		28.1		10							No																														19327	Yes					19329					22																30	483					Not Done							0	88.7									11080	1968-05-04
follow_up	ARDaC-AlcHepNet	11080_clinical_3	11080_clinical	11080_clinical_demographic	3												27.2		10							Yes																															No					19331					23										Yes, Mild																			3	85.9									11080	1968-05-04
follow_up	ARDaC-AlcHepNet	11080_clinical_7	11080_clinical	11080_clinical_demographic	7																																																									19336					22																													7										11080	1968-05-04
follow_up	ARDaC-AlcHepNet	11080_clinical_14	11080_clinical	11080_clinical_demographic	14																																																									19343																																		14										11080	1968-05-04
follow_up	ARDaC-AlcHepNet	11080_clinical_28	11080_clinical	11080_clinical_demographic	28																																																									19357																																		28										11080	1968-05-04
follow_up	ARDaC-AlcHepNet	11080_clinical_60	11080_clinical	11080_clinical_demographic	60																																																									19388																																		60										11080	1968-05-04
follow_up	ARDaC-AlcHepNet	11083_clinical_0	11083_clinical	11083_clinical_demographic	0												24.3		13							Yes																															No					24759					22										Yes, Mild						0	0												0	62.3									11083	1953-07-02
follow_up	ARDaC-AlcHepNet	11083_clinical_3	11083_clinical	11083_clinical_demographic	3												27.4		12							No																															No					24763					19																													3	70.2									11083	1953-07-02
follow_up	ARDaC-AlcHepNet	11083_clinical_7	11083_clinical	11083_clinical_demographic	7												26.3		10							Yes																															No					24766					15																													7	67.3									11083	1953-07-02
follow_up	ARDaC-AlcHepNet	11083_clinical_14	11083_clinical	11083_clinical_demographic	14		Not Done							24768	Negative		27.1		11							No																														24768	Yes					24773					16																0	0						24769			Negative			14	69.4									11083	1953-07-02
follow_up	ARDaC-AlcHepNet	11083_clinical_28	11083_clinical	11083_clinical_demographic	28												48.6		11							No																															No					24785					26																													28	124.5									11083	1953-07-02
follow_up	ARDaC-AlcHepNet	11083_clinical_60	11083_clinical	11083_clinical_demographic	60			Negative	24816					24818	Negative		21.9		13							No																														24801	Yes					24821					22																0	0						24801	Yes	Enterococcus faecium, Candida albicans	Positive			60	56.1									11083	1953-07-02
follow_up	ARDaC-AlcHepNet	11083_clinical_90	11083_clinical	11083_clinical_demographic	90			Negative	24821					24836	Negative		19.8		9							No																														24835	Yes					24849					17																0	0						24835	No; Positive for other organisms only	Klebsiella pneumoniae, Enterococcus faecium	Positive			90	50.8									11083	1953-07-02
follow_up	ARDaC-AlcHepNet	11083_clinical_180	11083_clinical	11083_clinical_demographic	180																																																																														0	0												180										11083	1953-07-02
follow_up	ARDaC-AlcHepNet	11085_clinical_0	11085_clinical	11085_clinical_demographic	0												45.7		13							No																															No					14823					28																0	0												0	161.4									11085	1980-09-19
follow_up	ARDaC-AlcHepNet	11085_clinical_3	11085_clinical	11085_clinical_demographic	3												46.6		13							No																															No					14825					31																													3	164.8									11085	1980-09-19
follow_up	ARDaC-AlcHepNet	11085_clinical_7	11085_clinical	11085_clinical_demographic	7												48.5		12							No																															No					14830					33																													7	171.4									11085	1980-09-19
follow_up	ARDaC-AlcHepNet	11085_clinical_14	11085_clinical	11085_clinical_demographic	14		Not Done							14837	Negative		47.2									Yes																														14837	Yes					14838																											Not Done							14	166.7									11085	1980-09-19
follow_up	ARDaC-AlcHepNet	11089_clinical_0	11089_clinical	11089_clinical_demographic	0		Not Done							11643	Negative		34.1		9							No																														11643	Yes					11649					24																28	193					Not Done							0	101.6									11089	1989-06-18
follow_up	ARDaC-AlcHepNet	11089_clinical_3	11089_clinical	11089_clinical_demographic	3												34.3		9							Yes				No	Large																										No					11651					24																													3	102.4									11089	1989-06-18
follow_up	ARDaC-AlcHepNet	11089_clinical_7	11089_clinical	11089_clinical_demographic	7												35.7		10							No																															No					11656					22																													7	106.4									11089	1989-06-18
follow_up	ARDaC-AlcHepNet	11089_clinical_14	11089_clinical	11089_clinical_demographic	14		Not Done							11663	Negative		22.9									Yes				Yes	Large	Yes	Large																							11663	Yes					11665					34										Yes, Moderate													11663			Negative			14	68.4									11089	1989-06-18
follow_up	ARDaC-AlcHepNet	11091_clinical_0	11091_clinical	11091_clinical_demographic	0												28.4		9							No																															No					25023					26																30	268												0	97.7									11091	1952-11-08
follow_up	ARDaC-AlcHepNet	11091_clinical_3	11091_clinical	11091_clinical_demographic	3												28.4		8							No																															No					25027					34																													3	97.7									11091	1952-11-08
follow_up	ARDaC-AlcHepNet	11091_clinical_7	11091_clinical	11091_clinical_demographic	7		Not Done							25028	Negative		30.3		7							Yes	25030																													25027	Yes					25030					34																							25027			Negative			7	104.2									11091	1952-11-08
follow_up	ARDaC-AlcHepNet	11091_clinical_14	11091_clinical	11091_clinical_demographic	14												29.8		9							No																															No					25037					36																													14	102.4									11091	1952-11-08
follow_up	ARDaC-AlcHepNet	11091_clinical_28	11091_clinical	11091_clinical_demographic	28			Negative	25045					25046	Negative		29.7		8							No																														25045	Yes					25051					40																							25047	No; Positive for other organisms only	Lactose positive gram negatice bacilli	Positive			28	102									11091	1952-11-08
follow_up	ARDaC-AlcHepNet	11092_clinical_0	11092_clinical	11092_clinical_demographic	0		Not Done							17912	Negative		27.6		9							No																														17912	Yes					17913					20																30	300					Not Done							0	75.3									11092	1972-05-10
follow_up	ARDaC-AlcHepNet	11092_clinical_3	11092_clinical	11092_clinical_demographic	3												28		8							Yes																															No					17916					18																													3	76.3									11092	1972-05-10
follow_up	ARDaC-AlcHepNet	11092_clinical_7	11092_clinical	11092_clinical_demographic	7												32.5		8							No																															No					17920					17																													7	88.7									11092	1972-05-10
follow_up	ARDaC-AlcHepNet	11092_clinical_14	11092_clinical	11092_clinical_demographic	14												31		8							No																															No					17927					18																													14	84.5									11092	1972-05-10
follow_up	ARDaC-AlcHepNet	11092_clinical_28	11092_clinical	11092_clinical_demographic	28		Not Done							17935	Positive	Micrococcus species; Comment: Probable contaminant, further work up not done and not indicated clinically	30.6		8							No																														17935	Yes					17941					17																0	0					Not Done							28	83.4									11092	1972-05-10
follow_up	ARDaC-AlcHepNet	11092_clinical_60	11092_clinical	11092_clinical_demographic	60		Not Done							17956	Positive	Finegoldia magna	26.9		6							No																														17956	Yes					17969					11																0	0					Not Done							60	73.4									11092	1972-05-10
follow_up	ARDaC-AlcHepNet	11092_clinical_90	11092_clinical	11092_clinical_demographic	90												25.5		6																																											17997					11																0	0												90	69.5									11092	1972-05-10
follow_up	ARDaC-AlcHepNet	11092_clinical_180	11092_clinical	11092_clinical_demographic	180												26		6							No																															No					18080					8																1	2												180	70.9									11092	1972-05-10
follow_up	ARDaC-AlcHepNet	11095_clinical_0	11095_clinical	11095_clinical_demographic	0												34.1		11							No																															No					23229					27																0	0												0	84.7									11095	1957-10-27
follow_up	ARDaC-AlcHepNet	11095_clinical_3	11095_clinical	11095_clinical_demographic	3		Not Done						No				34.1		11							No																														23232	Yes					23234					30																							23232	No; Positive for other organisms only	Klebsiella pneumoniae	Positive			3	84.7									11095	1957-10-27
follow_up	ARDaC-AlcHepNet	11095_clinical_7	11095_clinical	11095_clinical_demographic	7			Negative	23235					23235	Negative		33.6		13							No																														23235	Yes					23237					35																							23245			Negative			7	83.5									11095	1957-10-27
follow_up	ARDaC-AlcHepNet	11098_clinical_0	11098_clinical	11098_clinical_demographic	0		Not Done						No				21		9							No																														14231	Yes					14245					25																30	284						14231			Negative			0	72.3									11098	1982-06-15
follow_up	ARDaC-AlcHepNet	11098_clinical_3	11098_clinical	11098_clinical_demographic	3												21.2		8							No																															No					14247					24																													3	72.9									11098	1982-06-15
follow_up	ARDaC-AlcHepNet	11098_clinical_7	11098_clinical	11098_clinical_demographic	7		Not Done							14249	Negative		21.2		9							No																														14249	Yes					14251					25																							14249			Negative			7	72.9									11098	1982-06-15
follow_up	ARDaC-AlcHepNet	11098_clinical_14	11098_clinical	11098_clinical_demographic	14		Not Done						No				19.8		7							No																														14252	Yes					14258					26																							14252	No; Positive for other organisms only	Lactose negative gram negative bacilli	Positive			14	67.9									11098	1982-06-15
follow_up	ARDaC-AlcHepNet	11098_clinical_28	11098_clinical	11098_clinical_demographic	28												19.4		8							No																															No					14274					16																													28	66.7									11098	1982-06-15
follow_up	ARDaC-AlcHepNet	11098_clinical_60	11098_clinical	11098_clinical_demographic	60																																																									14311																																		60										11098	1982-06-15
follow_up	ARDaC-AlcHepNet	11098_clinical_90	11098_clinical	11098_clinical_demographic	90												20.9		8							No																															No					14335					14																0	0												90	72									11098	1982-06-15
follow_up	ARDaC-AlcHepNet	11098_clinical_180	11098_clinical	11098_clinical_demographic	180			Negative	14406					14405	Negative		20.9		10							Yes						No	Medium																							14405	Yes					14426					31										Yes, Moderate						0	0						14408			Negative			180	71.8									11098	1982-06-15
follow_up	ARDaC-AlcHepNet	11099_clinical_0	11099_clinical	11099_clinical_demographic	0			Negative	16526				No				25.8		10							No																														16526	Yes					16529					22																30	256					Not Done							0	79.4									11099	1976-03-16
follow_up	ARDaC-AlcHepNet	11099_clinical_3	11099_clinical	11099_clinical_demographic	3												25.4		9							No																															No					16533					19																													3	78.2									11099	1976-03-16
follow_up	ARDaC-AlcHepNet	11099_clinical_7	11099_clinical	11099_clinical_demographic	7												25.9		10							No																															No					16537					17																													7	79.6									11099	1976-03-16
follow_up	ARDaC-AlcHepNet	11099_clinical_14	11099_clinical	11099_clinical_demographic	14												25.9		10							No																															No					16543					16																													14	79.5									11099	1976-03-16
follow_up	ARDaC-AlcHepNet	11099_clinical_28	11099_clinical	11099_clinical_demographic	28												26.1		9							No																															No					16557					12																													28	80.3									11099	1976-03-16
follow_up	ARDaC-AlcHepNet	11099_clinical_60	11099_clinical	11099_clinical_demographic	60												26.1		5							No																															No					16589					8																0	0												60	80.1									11099	1976-03-16
follow_up	ARDaC-AlcHepNet	11099_clinical_90	11099_clinical	11099_clinical_demographic	90												26.1		5							No																															No					16620					7																0	0												90	80.1									11099	1976-03-16
follow_up	ARDaC-AlcHepNet	11099_clinical_180	11099_clinical	11099_clinical_demographic	180												28.2		5							No																															No					16704					7																0	0												180	86.7									11099	1976-03-16
follow_up	ARDaC-AlcHepNet	11103_clinical_0	11103_clinical	11103_clinical_demographic	0		Not Done							19247	Negative		17.1		9							Yes	19247																													19247	Yes					19250					20										Yes, Mild						30	240					Not Done							0	48.1									11103	1968-10-29
follow_up	ARDaC-AlcHepNet	11103_clinical_3	11103_clinical	11103_clinical_demographic	3												17.1		9							No																															No					19252					20																													3	48.1									11103	1968-10-29
follow_up	ARDaC-AlcHepNet	11103_clinical_7	11103_clinical	11103_clinical_demographic	7												16.1		8							No																															No					19256					19																													7	45.1									11103	1968-10-29
follow_up	ARDaC-AlcHepNet	11103_clinical_14	11103_clinical	11103_clinical_demographic	14												15.4		8							No																															No					19263					19																													14	43.3									11103	1968-10-29
follow_up	ARDaC-AlcHepNet	11103_clinical_28	11103_clinical	11103_clinical_demographic	28												15.8		10							No																															No					19278					16																													28	44.5									11103	1968-10-29
follow_up	ARDaC-AlcHepNet	11103_clinical_60	11103_clinical	11103_clinical_demographic	60												16		7							No																															No					19306					10																0	0												60	44.9									11103	1968-10-29
follow_up	ARDaC-AlcHepNet	11103_clinical_90	11103_clinical	11103_clinical_demographic	90												16.5		5							No																															No					19334					7																0	0												90	46.4									11103	1968-10-29
follow_up	ARDaC-AlcHepNet	11103_clinical_180	11103_clinical	11103_clinical_demographic	180												17.2		5							No																															No					19424					7																0	0												180	48.3									11103	1968-10-29
follow_up	ARDaC-AlcHepNet	11114_clinical_0	11114_clinical	11114_clinical_demographic	0			Negative	17735					17735	Negative		22.7		10							No																														17734	Yes					17738					20																27	108						17734	No; Positive for other organisms only	Klebsiella pnuemoniae	Positive			0	65.8									11114	1973-01-24
follow_up	ARDaC-AlcHepNet	11114_clinical_3	11114_clinical	11114_clinical_demographic	3												23.6		11							No																															No					17740					18																													3	68.5									11114	1973-01-24
follow_up	ARDaC-AlcHepNet	11114_clinical_7	11114_clinical	11114_clinical_demographic	7												23.4		10							No																															No					17745					20																													7	67.7									11114	1973-01-24
follow_up	ARDaC-AlcHepNet	11114_clinical_14	11114_clinical	11114_clinical_demographic	14			Negative	17746					17746	Negative		23		9							No																														17746	Yes					17752					18																						Not Done							14	66.5									11114	1973-01-24
follow_up	ARDaC-AlcHepNet	11114_clinical_28	11114_clinical	11114_clinical_demographic	28												21.4		9							No																															No					17766					18																0	0												28	62									11114	1973-01-24
follow_up	ARDaC-AlcHepNet	11114_clinical_60	11114_clinical	11114_clinical_demographic	60												21.2		8							No																															No					17793					18																0	0												60	61.4									11114	1973-01-24
follow_up	ARDaC-AlcHepNet	11114_clinical_90	11114_clinical	11114_clinical_demographic	90												21.8		8							Yes						Yes	Large																								No					17823					16										Yes, Severe						0	0												90	63.1									11114	1973-01-24
follow_up	ARDaC-AlcHepNet	11114_clinical_180	11114_clinical	11114_clinical_demographic	180												21.9		7							No																															No					17914					15																0	0												180	63.5									11114	1973-01-24
follow_up	ARDaC-AlcHepNet	11116_clinical_0	11116_clinical	11116_clinical_demographic	0		Not Done							17708	Negative		23		9							No																														17708	Yes					17710					23																25	206					Not Done							0	66.7									11116	1973-03-02
follow_up	ARDaC-AlcHepNet	11116_clinical_3	11116_clinical	11116_clinical_demographic	3												23		9							No																															No					17713					22																													3	66.7									11116	1973-03-02
follow_up	ARDaC-AlcHepNet	11116_clinical_7	11116_clinical	11116_clinical_demographic	7												23		11							No																															No					17716					22																													7	66.7									11116	1973-03-02
follow_up	ARDaC-AlcHepNet	11116_clinical_14	11116_clinical	11116_clinical_demographic	14		Not Done							17721	Negative		23		10							No																														17721	Yes					17723					24																						Not Done							14	66.7									11116	1973-03-02
follow_up	ARDaC-AlcHepNet	11116_clinical_28	11116_clinical	11116_clinical_demographic	28												24.3		9							No																															No					17738					21																0	0												28	70.4									11116	1973-03-02
follow_up	ARDaC-AlcHepNet	11116_clinical_60	11116_clinical	11116_clinical_demographic	60		Not Done							17751	Negative		21.3		8							Yes	17749					No	Small																							17751	Yes					17766					17																0	0						17748			Negative			60	61.8									11116	1973-03-02
follow_up	ARDaC-AlcHepNet	11116_clinical_90	11116_clinical	11116_clinical_demographic	90												22.4		9							No																															No					17807					15																0	0												90	64.9									11116	1973-03-02
follow_up	ARDaC-AlcHepNet	11116_clinical_180	11116_clinical	11116_clinical_demographic	180		Not Done							17856	Negative		21.7		8							No																														17856	Yes					17883					15																0	0					Not Done							180	62.9									11116	1973-03-02
follow_up	ARDaC-AlcHepNet	11118_clinical_0	11118_clinical	11118_clinical_demographic	0			Negative	17723					17723	Negative		46.1		10							No																														17719	Yes					17724					25																30	60						17719			Negative			0	145.6									11118	1973-03-02
follow_up	ARDaC-AlcHepNet	11118_clinical_3	11118_clinical	11118_clinical_demographic	3												46.1		10							No																															No					17727					25																													3	145.6									11118	1973-03-02
follow_up	ARDaC-AlcHepNet	11118_clinical_7	11118_clinical	11118_clinical_demographic	7												45.6		10							Yes						No	Large													No	Missing										No					17731					25										Yes, Mild																			7	144.2									11118	1973-03-02
follow_up	ARDaC-AlcHepNet	11118_clinical_14	11118_clinical	11118_clinical_demographic	14			Negative	17734				No				42.8		11							No																														17734	Yes					17738					24																						Not Done							14	135.3									11118	1973-03-02
follow_up	ARDaC-AlcHepNet	11118_clinical_28	11118_clinical	11118_clinical_demographic	28												46.3		11							No																															No					17752					20																0	0												28	146.4									11118	1973-03-02
follow_up	ARDaC-AlcHepNet	11118_clinical_60	11118_clinical	11118_clinical_demographic	60												45		11							Yes						No	Medium																								No					17783					18										Yes, Mild						0	0												60	142.2									11118	1973-03-02
follow_up	ARDaC-AlcHepNet	11118_clinical_90	11118_clinical	11118_clinical_demographic	90												44.3		10							No																															No					17821					21																0	0												90	140									11118	1973-03-02
follow_up	ARDaC-AlcHepNet	11118_clinical_180	11118_clinical	11118_clinical_demographic	180																																																									17911																																		180										11118	1973-03-02
follow_up	ARDaC-AlcHepNet	11122_clinical_0	11122_clinical	11122_clinical_demographic	0			Negative	18852					18852	Negative		26.2		11							No																														18852	Yes					18854					27																30	415					Not Done							0	64.9									11122	1970-02-09
follow_up	ARDaC-AlcHepNet	11122_clinical_3	11122_clinical	11122_clinical_demographic	3												26		11							No																															No					18855					25																													3	64.5									11122	1970-02-09
follow_up	ARDaC-AlcHepNet	11122_clinical_7	11122_clinical	11122_clinical_demographic	7																																																									18862																																		7										11122	1970-02-09
follow_up	ARDaC-AlcHepNet	11122_clinical_14	11122_clinical	11122_clinical_demographic	14																																																									18869																																		14										11122	1970-02-09
follow_up	ARDaC-AlcHepNet	11122_clinical_28	11122_clinical	11122_clinical_demographic	28																																																									18889																																		28										11122	1970-02-09
follow_up	ARDaC-AlcHepNet	11122_clinical_60	11122_clinical	11122_clinical_demographic	60																																																									18921																																		60										11122	1970-02-09
follow_up	ARDaC-AlcHepNet	11122_clinical_90	11122_clinical	11122_clinical_demographic	90																																																									18949																																		90										11122	1970-02-09
follow_up	ARDaC-AlcHepNet	11122_clinical_180	11122_clinical	11122_clinical_demographic	180																																																									19041																																		180										11122	1970-02-09
follow_up	ARDaC-AlcHepNet	11125_clinical_0	11125_clinical	11125_clinical_demographic	0		Not Done							14480	Negative				9							No																														14480	Yes					14499					26																28	108						14480	No; Positive for other organisms only	Klebsiella Pneumoniae	Positive			0										11125	1982-03-13
follow_up	ARDaC-AlcHepNet	11125_clinical_3	11125_clinical	11125_clinical_demographic	3												33.3		9							No																															No					14501					26																													3	82.7									11125	1982-03-13
follow_up	ARDaC-AlcHepNet	11125_clinical_7	11125_clinical	11125_clinical_demographic	7												34.5		9							Yes																															No					14506					29										Yes, Moderate																			7	85.6									11125	1982-03-13
follow_up	ARDaC-AlcHepNet	11125_clinical_14	11125_clinical	11125_clinical_demographic	14			Negative	14507					14507	Negative		34.1		8							No																														14507	Yes					14513					30																							14507	No; Positive for other organisms only	Enterococcus faecalis	Positive			14	84.6									11125	1982-03-13
follow_up	ARDaC-AlcHepNet	11125_clinical_28	11125_clinical	11125_clinical_demographic	28		Not Done							14521	Negative		35.2		10							No																														14521	Yes					14522					37																0	0					Not Done							28	87.2									11125	1982-03-13
follow_up	ARDaC-AlcHepNet	11128_clinical_0	11128_clinical	11128_clinical_demographic	0			Negative	15869					15866	Negative		19.3		10							Yes						No	Small																							15865	Yes					15870					25																19	59						15865			Negative			0	66.2									11128	1978-07-04
follow_up	ARDaC-AlcHepNet	11128_clinical_3	11128_clinical	11128_clinical_demographic	3												19.3		9							No																															No					15872					27																													3	66.2									11128	1978-07-04
follow_up	ARDaC-AlcHepNet	11128_clinical_7	11128_clinical	11128_clinical_demographic	7												21.2		11							No																															No					15876					27																													7	72.7									11128	1978-07-04
follow_up	ARDaC-AlcHepNet	11128_clinical_14	11128_clinical	11128_clinical_demographic	14												23.2		10							No																															No					15883					25																													14	79.7									11128	1978-07-04
follow_up	ARDaC-AlcHepNet	11128_clinical_28	11128_clinical	11128_clinical_demographic	28																																																																														0	0												28										11128	1978-07-04
follow_up	ARDaC-AlcHepNet	11128_clinical_60	11128_clinical	11128_clinical_demographic	60		Not Done						No				19.4		10							Yes						No	Small																							15914	Yes					15931					31										Missing						0	0						15914			Negative			60	66.7									11128	1978-07-04
follow_up	ARDaC-AlcHepNet	11128_clinical_90	11128_clinical	11128_clinical_demographic	90			Negative	15949					15949	Negative		26.7									No																														15949	Yes					15959					28																0	0					Not Done							90	91.8									11128	1978-07-04
follow_up	ARDaC-AlcHepNet	11131_clinical_0	11131_clinical	11131_clinical_demographic	0		Not Done							20434	Negative		20.7		10							No																														20434	Yes					20436					23																30	150					Not Done							0	74									11131	1966-02-01
follow_up	ARDaC-AlcHepNet	11131_clinical_7	11131_clinical	11131_clinical_demographic	7												25		10							Yes						No	Small																								No					20443					26										Yes, Mild																			7	89.6									11131	1966-02-01
follow_up	ARDaC-AlcHepNet	11131_clinical_14	11131_clinical	11131_clinical_demographic	14			Negative	20448				No				25.3		11							No																														20447	Yes					20449					33																							20447			Negative			14	90.5									11131	1966-02-01
follow_up	ARDaC-AlcHepNet	11131_clinical_28	11131_clinical	11131_clinical_demographic	28			Negative	20459					20456	Negative		25.4		9							Yes						No	Medium																							20456	Yes					20462					34										Yes, Mild						0	0						20456	No; Positive for other organisms only	Enterococcus faecalis	Positive			28	91.1									11131	1966-02-01
follow_up	ARDaC-AlcHepNet	11132_clinical_0	11132_clinical	11132_clinical_demographic	0												37.7		12							No																															No					17361					25																30	252												0	122									11132	1974-07-14
follow_up	ARDaC-AlcHepNet	11132_clinical_3	11132_clinical	11132_clinical_demographic	3												37.2		12							No																															No					17363					26																													3	120.4									11132	1974-07-14
follow_up	ARDaC-AlcHepNet	11132_clinical_7	11132_clinical	11132_clinical_demographic	7		Not Done							17365	Negative		33.3		8							No																														17365	Yes					17368					25																						Not Done							7	107.5									11132	1974-07-14
follow_up	ARDaC-AlcHepNet	11132_clinical_14	11132_clinical	11132_clinical_demographic	14												28.9		8							No																															No					17375					25																													14	93.4									11132	1974-07-14
follow_up	ARDaC-AlcHepNet	11132_clinical_28	11132_clinical	11132_clinical_demographic	28																																																																														0	0												28										11132	1974-07-14
follow_up	ARDaC-AlcHepNet	11132_clinical_60	11132_clinical	11132_clinical_demographic	60		Not Done							17414	Negative		36.7									Yes	17414					Missing	Small																							17414	Yes										38										Missing						0	0						17414			Negative			60	118.7									11132	1974-07-14
follow_up	ARDaC-AlcHepNet	11139_clinical_0	11139_clinical	11139_clinical_demographic	0		Not Done						No				31		8							No																														17278	Yes					17280					22																23	92						17278	No; Positive for other organisms only	Mixed microbiota	Positive			0	84.4									11139	1974-11-04
follow_up	ARDaC-AlcHepNet	11139_clinical_3	11139_clinical	11139_clinical_demographic	3		Not Done							17281	Negative		30.9		9							No																														17281	Yes					17283					22																						Not Done							3	84.3									11139	1974-11-04
follow_up	ARDaC-AlcHepNet	11139_clinical_7	11139_clinical	11139_clinical_demographic	7												30.7		9							No																															No					17286					20																													7	83.8									11139	1974-11-04
follow_up	ARDaC-AlcHepNet	11139_clinical_14	11139_clinical	11139_clinical_demographic	14		Not Done						No				30.9		8							No																														17293	Yes					17293					18																							17293	No; Positive for other organisms only	Enterococcus faecalis, Gram negative bacilli	Positive			14	84.2									11139	1974-11-04
follow_up	ARDaC-AlcHepNet	11139_clinical_28	11139_clinical	11139_clinical_demographic	28			Negative	17298				No				29.2		9							No																														17293	Yes										26																0	0						17293	No; Positive for other organisms only	Enterococcus faecalis; Gram negative bacilli	Positive			28	79.5									11139	1974-11-04
follow_up	ARDaC-AlcHepNet	11139_clinical_60	11139_clinical	11139_clinical_demographic	60			Negative	17334					17334	Negative		26.7		10							Yes	17328																													17334	Yes										25																0	0						17335			Negative			60	72.8									11139	1974-11-04
follow_up	ARDaC-AlcHepNet	21034_clinical_0	21034_clinical	21034_clinical_demographic	0			Negative	25125					25124	Negative		22.6		8							No																														25124	Yes										22																							25124			Negative			0	71.4									21034	1951-10-08
follow_up	ARDaC-AlcHepNet	21034_clinical_7	21034_clinical	21034_clinical_demographic	7														10																																											25137					19																													7										21034	1951-10-08
follow_up	ARDaC-AlcHepNet	21034_clinical_14	21034_clinical	21034_clinical_demographic	14			Negative	25145					25144	Negative		24		12							No																														25144	Yes					25146					21																						Not Done							14	75.8									21034	1951-10-08
follow_up	ARDaC-AlcHepNet	21034_clinical_28	21034_clinical	21034_clinical_demographic	28																																																									25159					20																													28										21034	1951-10-08
follow_up	ARDaC-AlcHepNet	21034_clinical_60	21034_clinical	21034_clinical_demographic	60												25.5		12																																																17																													60	80.6									21034	1951-10-08
follow_up	ARDaC-AlcHepNet	21034_clinical_90	21034_clinical	21034_clinical_demographic	90																																																									25214					18																													90										21034	1951-10-08
follow_up	ARDaC-AlcHepNet	21034_clinical_180	21034_clinical	21034_clinical_demographic	180																																																									25305					10																													180										21034	1951-10-08
follow_up	ARDaC-AlcHepNet	21035_clinical_0	21035_clinical	21035_clinical_demographic	0												32.3		11																																											16837					28																													0										21035	1974-06-05
follow_up	ARDaC-AlcHepNet	21035_clinical_3	21035_clinical	21035_clinical_demographic	3			Negative	16837				No				34.5		11							No																														16837	Yes					16840					27																						Not Done							3	94									21035	1974-06-05
follow_up	ARDaC-AlcHepNet	21035_clinical_7	21035_clinical	21035_clinical_demographic	7												34.5		11																																											16844					31																													7	94									21035	1974-06-05
follow_up	ARDaC-AlcHepNet	21035_clinical_14	21035_clinical	21035_clinical_demographic	14																																																									16856					28																													14										21035	1974-06-05
follow_up	ARDaC-AlcHepNet	21035_clinical_28	21035_clinical	21035_clinical_demographic	28			Negative	16862					16861	Negative		35.3		13							No																														16861	Yes					16863					26																0	0						16861	No; Positive for other organisms only	VRE	Positive			28	96.3									21035	1974-06-05
follow_up	ARDaC-AlcHepNet	21035_clinical_60	21035_clinical	21035_clinical_demographic	60												30.3		10							No																															No					16904					15																0	0												60	82.7									21035	1974-06-05
follow_up	ARDaC-AlcHepNet	21035_clinical_90	21035_clinical	21035_clinical_demographic	90																																																									16938					16																													90										21035	1974-06-05
follow_up	ARDaC-AlcHepNet	21035_clinical_180	21035_clinical	21035_clinical_demographic	180																																																									17024					12																													180										21035	1974-06-05
follow_up	ARDaC-AlcHepNet	21036_clinical_0	21036_clinical	21036_clinical_demographic	0		Not Done							13360	Negative		37.7		12							Yes	13351					No	Large																							13360	Yes					13366					27										Yes, Severe						30	250.5						13362			Negative			0	116									21036	1983-12-25
follow_up	ARDaC-AlcHepNet	21036_clinical_3	21036_clinical	21036_clinical_demographic	3																																																									13369					32																													3										21036	1983-12-25
follow_up	ARDaC-AlcHepNet	21036_clinical_7	21036_clinical	21036_clinical_demographic	7		Not Done							13372	Negative				12							No																														13373	Yes					13373					27																						Not Done							7										21036	1983-12-25
follow_up	ARDaC-AlcHepNet	21036_clinical_28	21036_clinical	21036_clinical_demographic	28												32.6		12							No																															No					13387					25																0	0												28	100.1									21036	1983-12-25
follow_up	ARDaC-AlcHepNet	21036_clinical_90	21036_clinical	21036_clinical_demographic	90		Not Done							13436	Negative		44.5		9							No																														13436	Yes					13442					27																0	0						13437			Negative			90	136.6									21036	1983-12-25
follow_up	ARDaC-AlcHepNet	21038_clinical_0	21038_clinical	21038_clinical_demographic	0												29.9		7																																											11757					26																													0	85.1									21038	1988-05-21
follow_up	ARDaC-AlcHepNet	21038_clinical_7	21038_clinical	21038_clinical_demographic	7												29.1		8							No																															No					11765					23																													7	82.7									21038	1988-05-21
follow_up	ARDaC-AlcHepNet	21038_clinical_14	21038_clinical	21038_clinical_demographic	14												28.4		8							No																															No					11772					19																													14	80.9									21038	1988-05-21
follow_up	ARDaC-AlcHepNet	21038_clinical_28	21038_clinical	21038_clinical_demographic	28		Not Done							11775	Positive	staphylococcus aureus			8							No																														11775	Yes					11786					13																						Not Done							28	81.6									21038	1988-05-21
follow_up	ARDaC-AlcHepNet	21038_clinical_60	21038_clinical	21038_clinical_demographic	60												30.4		5							No																															No					11813					8																													60	86.4									21038	1988-05-21
follow_up	ARDaC-AlcHepNet	21038_clinical_180	21038_clinical	21038_clinical_demographic	180														5							No																															No					11933					7																0	0												180	95									21038	1988-05-21
follow_up	ARDaC-AlcHepNet	21039_clinical_0	21039_clinical	21039_clinical_demographic	0												33.4		12																																											12390					32																30	255												0	96.6									21039	1986-10-23
follow_up	ARDaC-AlcHepNet	21039_clinical_3	21039_clinical	21039_clinical_demographic	3																																																									12440					29																													3										21039	1986-10-23
follow_up	ARDaC-AlcHepNet	21039_clinical_7	21039_clinical	21039_clinical_demographic	7																																																									12397					27																													7										21039	1986-10-23
follow_up	ARDaC-AlcHepNet	21039_clinical_14	21039_clinical	21039_clinical_demographic	14												28.1		9																																											12402					26																													14	81.3									21039	1986-10-23
follow_up	ARDaC-AlcHepNet	21040_clinical_0	21040_clinical	21040_clinical_demographic	0		Not Done							11869	Negative		29.7		9							No																														11868	Yes					11870					25																14	177						11868	No; Positive for other organisms only	enterococcus faecalis	Positive			0	96.2									21040	1989-04-23
follow_up	ARDaC-AlcHepNet	21043_clinical_0	21043_clinical	21043_clinical_demographic	0												38.3		12																																											10791					27																													0	95									21043	1991-08-19
follow_up	ARDaC-AlcHepNet	21043_clinical_3	21043_clinical	21043_clinical_demographic	3														11																																											10795					30																													3										21043	1991-08-19
follow_up	ARDaC-AlcHepNet	21043_clinical_7	21043_clinical	21043_clinical_demographic	7														9							No																															No					10798					28																													7										21043	1991-08-19
follow_up	ARDaC-AlcHepNet	21043_clinical_14	21043_clinical	21043_clinical_demographic	14														10							No																															No					10804					27																													14	80.9									21043	1991-08-19
follow_up	ARDaC-AlcHepNet	21043_clinical_28	21043_clinical	21043_clinical_demographic	28												33.2									No																															No																										0	0												28	82.4									21043	1991-08-19
follow_up	ARDaC-AlcHepNet	21043_clinical_60	21043_clinical	21043_clinical_demographic	60																																																									10851					15																													60										21043	1991-08-19
follow_up	ARDaC-AlcHepNet	21044_clinical_0	21044_clinical	21044_clinical_demographic	0												26.2		11							No																															No					14315					29																25	175												0	74.3									21044	1981-12-30
follow_up	ARDaC-AlcHepNet	21044_clinical_3	21044_clinical	21044_clinical_demographic	3												26.2		10																																											14317					32																													3	74.3									21044	1981-12-30
follow_up	ARDaC-AlcHepNet	21044_clinical_7	21044_clinical	21044_clinical_demographic	7			Negative	14324				No				26.7		12							No																														14324	Yes					14324					32																						Not Done							7	72.8									21044	1981-12-30
follow_up	ARDaC-AlcHepNet	21044_clinical_14	21044_clinical	21044_clinical_demographic	14		Not Done							14326	Negative		30		11							No																														14326	Yes					14330					33																10	39					Not Done							14	81.9									21044	1981-12-30
follow_up	ARDaC-AlcHepNet	21044_clinical_28	21044_clinical	21044_clinical_demographic	28			Negative	14343				No				25.1		10							No																														14343	Yes					14345					36																						Not Done							28	68.4									21044	1981-12-30
follow_up	ARDaC-AlcHepNet	21044_clinical_60	21044_clinical	21044_clinical_demographic	60																																																									14376					23																													60										21044	1981-12-30
follow_up	ARDaC-AlcHepNet	21044_clinical_90	21044_clinical	21044_clinical_demographic	90																																																									14398																																		90										21044	1981-12-30
follow_up	ARDaC-AlcHepNet	21045_clinical_0	21045_clinical	21045_clinical_demographic	0		Not Done							14454	Negative		35.3		6							No																														14454	Yes					14459					29																25	224						14454			Negative			0	128.1									21045	1981-08-14
follow_up	ARDaC-AlcHepNet	21045_clinical_3	21045_clinical	21045_clinical_demographic	3																																																									14462					30																													3										21045	1981-08-14
follow_up	ARDaC-AlcHepNet	21045_clinical_7	21045_clinical	21045_clinical_demographic	7		Not Done							14466	Negative		37.6		7							No																														14466	Yes					14467					26																						Not Done							7	136.3									21045	1981-08-14
follow_up	ARDaC-AlcHepNet	21045_clinical_14	21045_clinical	21045_clinical_demographic	14												35.5		6							No																															No					14475					23																													14	128.8									21045	1981-08-14
follow_up	ARDaC-AlcHepNet	21045_clinical_28	21045_clinical	21045_clinical_demographic	28												29.9		5							No																															No					14495					16																0	0												28	108.4									21045	1981-08-14
follow_up	ARDaC-AlcHepNet	21045_clinical_60	21045_clinical	21045_clinical_demographic	60																																																									14528					15																													60										21045	1981-08-14
follow_up	ARDaC-AlcHepNet	21045_clinical_90	21045_clinical	21045_clinical_demographic	90																																																									14550					13																													90										21045	1981-08-14
follow_up	ARDaC-AlcHepNet	21046_clinical_0	21046_clinical	21046_clinical_demographic	0			Negative	21345					21345	Negative		26.5		10							No																														21345	Yes					21350					30																8	35					Not Done							0	96.3									21046	1962-11-07
follow_up	ARDaC-AlcHepNet	21046_clinical_3	21046_clinical	21046_clinical_demographic	3												26.5		10							No																															No					21352					30																													3	96.3									21046	1962-11-07
follow_up	ARDaC-AlcHepNet	21046_clinical_7	21046_clinical	21046_clinical_demographic	7												24		11							No																															No					21357					29																													7	87									21046	1962-11-07
follow_up	ARDaC-AlcHepNet	21046_clinical_14	21046_clinical	21046_clinical_demographic	14												26.5		11							No																															No					21365					28																													14	188.8									21046	1962-11-07
follow_up	ARDaC-AlcHepNet	21046_clinical_28	21046_clinical	21046_clinical_demographic	28												21.3		9							No																															No					21380					25																													28	77.4									21046	1962-11-07
follow_up	ARDaC-AlcHepNet	21046_clinical_60	21046_clinical	21046_clinical_demographic	60		Not Done										22.5									No																															No																										0	0					Not Done							60	81.6									21046	1962-11-07
follow_up	ARDaC-AlcHepNet	21046_clinical_90	21046_clinical	21046_clinical_demographic	90																																																									21436					23																													90										21046	1962-11-07
follow_up	ARDaC-AlcHepNet	21046_clinical_180	21046_clinical	21046_clinical_demographic	180																																																									21524					20																													180										21046	1962-11-07
follow_up	ARDaC-AlcHepNet	21047_clinical_0	21047_clinical	21047_clinical_demographic	0			Negative	21482					21486	Negative		22.7		9							No																														21486	Yes					21488					25																15	74						21485			Negative			0	83.2									21047	1962-06-24
follow_up	ARDaC-AlcHepNet	21047_clinical_3	21047_clinical	21047_clinical_demographic	3			Negative	21491				No				22.6		10							No																														21491	Yes					21491					26																						Not Done							3	83.2									21047	1962-06-24
follow_up	ARDaC-AlcHepNet	21047_clinical_7	21047_clinical	21047_clinical_demographic	7												18.9		9																																											21498					22																													7	69.4									21047	1962-06-24
follow_up	ARDaC-AlcHepNet	21047_clinical_14	21047_clinical	21047_clinical_demographic	14												18.7		9							No																															No					21502					22																													14	68.8									21047	1962-06-24
follow_up	ARDaC-AlcHepNet	21047_clinical_28	21047_clinical	21047_clinical_demographic	28												19.4		12																																											21530					20																													28	72.2									21047	1962-06-24
follow_up	ARDaC-AlcHepNet	21047_clinical_60	21047_clinical	21047_clinical_demographic	60			Missing						21554	Negative		19.4		8							No																														21554	Yes					21554					18																0	0									Missing			60	67.3									21047	1962-06-24
follow_up	ARDaC-AlcHepNet	21047_clinical_90	21047_clinical	21047_clinical_demographic	90												18.1		9							No																															No					21579					20																0	0												90	70									21047	1962-06-24
follow_up	ARDaC-AlcHepNet	21047_clinical_180	21047_clinical	21047_clinical_demographic	180																																																									21579					20																													180										21047	1962-06-24
follow_up	ARDaC-AlcHepNet	21048_clinical_0	21048_clinical	21048_clinical_demographic	0												23.5		9							No																															No					11362					24																14	158												0	68									21048	1990-03-28
follow_up	ARDaC-AlcHepNet	21048_clinical_7	21048_clinical	21048_clinical_demographic	7												24.6		9							No																															No					11370					20																													7	71.3									21048	1990-03-28
follow_up	ARDaC-AlcHepNet	21048_clinical_14	21048_clinical	21048_clinical_demographic	14												24.3		7							No																															No					11377					18																													14	70.5									21048	1990-03-28
follow_up	ARDaC-AlcHepNet	21048_clinical_28	21048_clinical	21048_clinical_demographic	28												23.4		8							No																															No					11391					14																7	24												28	67.7									21048	1990-03-28
follow_up	ARDaC-AlcHepNet	21048_clinical_180	21048_clinical	21048_clinical_demographic	180												23.8		5							No																															No					11584					11																0	0												180	68.8									21048	1990-03-28
follow_up	ARDaC-AlcHepNet	21054_clinical_0	21054_clinical	21054_clinical_demographic	0		Not Done							15110	Negative		32.4		10							No																														15110	Yes					15112					27																27	240						15110			Negative			0	90.9									21054	1980-01-11
follow_up	ARDaC-AlcHepNet	21054_clinical_3	21054_clinical	21054_clinical_demographic	3														10							No																															No					15113					29																													3										21054	1980-01-11
follow_up	ARDaC-AlcHepNet	21054_clinical_7	21054_clinical	21054_clinical_demographic	7												31.8		8							No																															No					15119					29																													7	85.7									21054	1980-01-11
follow_up	ARDaC-AlcHepNet	21054_clinical_14	21054_clinical	21054_clinical_demographic	14												31		11							No																															No					15127					35																													14	84.6									21054	1980-01-11
follow_up	ARDaC-AlcHepNet	21054_clinical_28	21054_clinical	21054_clinical_demographic	28			Negative	15128					15128	Negative		29.4		5							No																														15128	Yes					15146					24																							15128			Negative			28	80.4									21054	1980-01-11
follow_up	ARDaC-AlcHepNet	21054_clinical_60	21054_clinical	21054_clinical_demographic	60												29.1		7							No																															No					15174					17																0	0												60	79.3									21054	1980-01-11
follow_up	ARDaC-AlcHepNet	21054_clinical_90	21054_clinical	21054_clinical_demographic	90												29.5		7							No																															No					15197					15																0	0												90	80.5									21054	1980-01-11
follow_up	ARDaC-AlcHepNet	21054_clinical_180	21054_clinical	21054_clinical_demographic	180												30.3		5							Yes	15259					No	Small																								No					15285					11										Yes, Moderate						0	0												180	85									21054	1980-01-11
follow_up	ARDaC-AlcHepNet	21055_clinical_0	21055_clinical	21055_clinical_demographic	0		Not Done							22152	Negative		19.9		9							No																														22152	Yes					22160					26																1	4						22152	No; Positive for other organisms only	Escherichia coli	Positive			0	61.3									21055	1960-10-20
follow_up	ARDaC-AlcHepNet	21058_clinical_0	21058_clinical	21058_clinical_demographic	0		Not Done							16625	Negative		38.2		10							No																														16625	Yes					16629					26																25	102					Not Done							0	97.8									21058	1976-02-12
follow_up	ARDaC-AlcHepNet	21058_clinical_3	21058_clinical	21058_clinical_demographic	3			Negative	16632					16628	Positive	Prelim gram + cocci on 08-24-2021, micrococcus luteus on 08-25-2021			12							No																														16628	Yes					16632					35																							16629	No; Positive for other organisms only	E coli	Positive			3										21058	1976-02-12
follow_up	ARDaC-AlcHepNet	21058_clinical_7	21058_clinical	21058_clinical_demographic	7			Negative	16636				No				38.2		9							No																														16636	Yes					16636					30																						Not Done							7	97.8									21058	1976-02-12
follow_up	ARDaC-AlcHepNet	21058_clinical_14	21058_clinical	21058_clinical_demographic	14												39.9		11							No																															No					16644					27																													14	99.1									21058	1976-02-12
follow_up	ARDaC-AlcHepNet	21058_clinical_28	21058_clinical	21058_clinical_demographic	28												39.7		11							No																															No					16657					24																0	0												28	98.7									21058	1976-02-12
follow_up	ARDaC-AlcHepNet	21058_clinical_60	21058_clinical	21058_clinical_demographic	60												36		11							No																															No					16686					19																0	0												60	92.1									21058	1976-02-12
follow_up	ARDaC-AlcHepNet	21058_clinical_90	21058_clinical	21058_clinical_demographic	90												33.6		10							No																															No					16714					17																0	0												90	85.9									21058	1976-02-12
follow_up	ARDaC-AlcHepNet	21058_clinical_180	21058_clinical	21058_clinical_demographic	180												31.4		7							No																															No					16806					14																0	0												180	80.4									21058	1976-02-12
follow_up	ARDaC-AlcHepNet	21069_clinical_0	21069_clinical	21069_clinical_demographic	0		Not Done							16716	Negative		26.4		9							No																														16716	Yes										23																28	200						16716			Negative			0	71.9									21069	1975-12-22
follow_up	ARDaC-AlcHepNet	21069_clinical_3	21069_clinical	21069_clinical_demographic	3												26.2		6							No																															No					16723					19																													3	71.3									21069	1975-12-22
follow_up	ARDaC-AlcHepNet	21069_clinical_7	21069_clinical	21069_clinical_demographic	7												25.7		6							No																															No					16727					20																													7	70									21069	1975-12-22
follow_up	ARDaC-AlcHepNet	21069_clinical_14	21069_clinical	21069_clinical_demographic	14												25.1		9							No																															No					16734					19																													14	68.3									21069	1975-12-22
follow_up	ARDaC-AlcHepNet	21069_clinical_28	21069_clinical	21069_clinical_demographic	28												24.2		8							No																															No					16760					16																0	0												28	66.1									21069	1975-12-22
follow_up	ARDaC-AlcHepNet	21069_clinical_60	21069_clinical	21069_clinical_demographic	60												23.8		7																																											16780					13																1	2												60	65									21069	1975-12-22
follow_up	ARDaC-AlcHepNet	21073_clinical_0	21073_clinical	21073_clinical_demographic	0		Not Done							13201	Negative		28.4		10							No																														13201	Yes					13201					30																24	56					Not Done							0	70.4									21073	1985-08-30
follow_up	ARDaC-AlcHepNet	21073_clinical_3	21073_clinical	21073_clinical_demographic	3														11							No																															No					13205					29																													3										21073	1985-08-30
follow_up	ARDaC-AlcHepNet	21073_clinical_7	21073_clinical	21073_clinical_demographic	7												28.2		9							No																															No					13208					28																													7	69.9									21073	1985-08-30
follow_up	ARDaC-AlcHepNet	21073_clinical_14	21073_clinical	21073_clinical_demographic	14												29.1		11							No																															No					13215					27																													14	72									21073	1985-08-30
follow_up	ARDaC-AlcHepNet	21073_clinical_28	21073_clinical	21073_clinical_demographic	28												29.1		11							No																															No					13229					39																0	0												28	72.1									21073	1985-08-30
follow_up	ARDaC-AlcHepNet	21076_clinical_0	21076_clinical	21076_clinical_demographic	0												24.8		9							No																															No					20628					23																24	168												0	76.1									21076	1965-05-25
follow_up	ARDaC-AlcHepNet	21076_clinical_3	21076_clinical	21076_clinical_demographic	3														9																																											20631					21																													3										21076	1965-05-25
follow_up	ARDaC-AlcHepNet	21076_clinical_7	21076_clinical	21076_clinical_demographic	7												26.6		9																																											20635					20																													7	81.8									21076	1965-05-25
follow_up	ARDaC-AlcHepNet	21076_clinical_14	21076_clinical	21076_clinical_demographic	14												27.4		10							No																															No					20642					20																													14	84.1									21076	1965-05-25
follow_up	ARDaC-AlcHepNet	21076_clinical_28	21076_clinical	21076_clinical_demographic	28												24.8		10							No																															No					20656					18																0	0												28	76.1									21076	1965-05-25
follow_up	ARDaC-AlcHepNet	21076_clinical_60	21076_clinical	21076_clinical_demographic	60												24.1		8							No																															No					20695					11																0	0												60	74.2									21076	1965-05-25
follow_up	ARDaC-AlcHepNet	21076_clinical_90	21076_clinical	21076_clinical_demographic	90												26.4		5							No																															No					20719					8																0	0												90	81.2									21076	1965-05-25
follow_up	ARDaC-AlcHepNet	21081_clinical_0	21081_clinical	21081_clinical_demographic	0			Missing						16737	Negative		25.2		6							No																														16737	Yes					16739					22																25	200									Missing			0	66.5									21081	1976-04-10
follow_up	ARDaC-AlcHepNet	21081_clinical_3	21081_clinical	21081_clinical_demographic	3														7							No																															No					16741					20																													3										21081	1976-04-10
follow_up	ARDaC-AlcHepNet	21081_clinical_7	21081_clinical	21081_clinical_demographic	7												30.7		10							No																															No					16746					18																													7	81.2									21081	1976-04-10
follow_up	ARDaC-AlcHepNet	21081_clinical_14	21081_clinical	21081_clinical_demographic	14												25.4		10							No																															No					16753					15																													14	67.1									21081	1976-04-10
follow_up	ARDaC-AlcHepNet	31033_clinical_0	31033_clinical	31033_clinical_demographic	0												27.2		10																																											17879					22																													0	82									31033	1972-01-27
follow_up	ARDaC-AlcHepNet	31033_clinical_3	31033_clinical	31033_clinical_demographic	3														10																																											17882					21																													3										31033	1972-01-27
follow_up	ARDaC-AlcHepNet	31033_clinical_7	31033_clinical	31033_clinical_demographic	7												33.1		11																																											17886					19																													7	101.6									31033	1972-01-27
follow_up	ARDaC-AlcHepNet	31033_clinical_14	31033_clinical	31033_clinical_demographic	14												33.1		10																																											17893					20																													14	101.6									31033	1972-01-27
follow_up	ARDaC-AlcHepNet	31033_clinical_28	31033_clinical	31033_clinical_demographic	28												26.7		9																																											17906					21																0	0												28	82.5									31033	1972-01-27
follow_up	ARDaC-AlcHepNet	31033_clinical_60	31033_clinical	31033_clinical_demographic	60												26.7		9																																											17942					21																0	0												60	82.1									31033	1972-01-27
follow_up	ARDaC-AlcHepNet	31033_clinical_90	31033_clinical	31033_clinical_demographic	90												27.4		8																																											17966					19																0	0												90	84.1									31033	1972-01-27
follow_up	ARDaC-AlcHepNet	31033_clinical_180	31033_clinical	31033_clinical_demographic	180														9																																											18061					19																1	2												180	81.4									31033	1972-01-27
follow_up	ARDaC-AlcHepNet	31036_clinical_0	31036_clinical	31036_clinical_demographic	0												29		9							No																															No					10790					22																22	460												0	97									31036	1991-07-09
follow_up	ARDaC-AlcHepNet	31036_clinical_3	31036_clinical	31036_clinical_demographic	3												29		9																																											10794					18																													3	97									31036	1991-07-09
follow_up	ARDaC-AlcHepNet	31036_clinical_7	31036_clinical	31036_clinical_demographic	7												29		9																																											10797					16																													7	97									31036	1991-07-09
follow_up	ARDaC-AlcHepNet	31036_clinical_14	31036_clinical	31036_clinical_demographic	14												30		9							No																															No					10804					13																													14	100.4									31036	1991-07-09
follow_up	ARDaC-AlcHepNet	31036_clinical_28	31036_clinical	31036_clinical_demographic	28												32.8									No																															No																																							28	105									31036	1991-07-09
follow_up	ARDaC-AlcHepNet	31041_clinical_0	31041_clinical	31041_clinical_demographic	0												39.8		11							No																															No					19980					23																22	374												0	125.1									31041	1966-07-06
follow_up	ARDaC-AlcHepNet	31041_clinical_7	31041_clinical	31041_clinical_demographic	7												41.6		9							No																															No					19991					14																													7	130.2									31041	1966-07-06
follow_up	ARDaC-AlcHepNet	31041_clinical_28	31041_clinical	31041_clinical_demographic	28												35.6		8							No																															No					20005					15																0	0												28	112.2									31041	1966-07-06
follow_up	ARDaC-AlcHepNet	31042_clinical_0	31042_clinical	31042_clinical_demographic	0												51.7		12																																											18919					27																													0	124.2									31042	1969-06-13
follow_up	ARDaC-AlcHepNet	31042_clinical_3	31042_clinical	31042_clinical_demographic	3												51		12							No																															No					18922					26																													3	121.4									31042	1969-06-13
follow_up	ARDaC-AlcHepNet	31042_clinical_7	31042_clinical	31042_clinical_demographic	7												45		10																																											18922					26																													7	107.2									31042	1969-06-13
follow_up	ARDaC-AlcHepNet	31042_clinical_14	31042_clinical	31042_clinical_demographic	14			Negative	18934					18934	Positive	Streptococcus agalactiae (Group B)	42.9		13							No																														18934	Yes					18934					30																0	0						18934			Negative			14	103									31042	1969-06-13
follow_up	ARDaC-AlcHepNet	31042_clinical_28	31042_clinical	31042_clinical_demographic	28												39.7		9							No																															No					18949					22																													28	95.7									31042	1969-06-13
follow_up	ARDaC-AlcHepNet	31042_clinical_60	31042_clinical	31042_clinical_demographic	60												41.3		9							No																															No					18969					22																0	0												60	99.3									31042	1969-06-13
follow_up	ARDaC-AlcHepNet	31042_clinical_90	31042_clinical	31042_clinical_demographic	90												41.8		11																																																26																0	0												90	100									31042	1969-06-13
follow_up	ARDaC-AlcHepNet	31043_clinical_0	31043_clinical	31043_clinical_demographic	0		Not Done							21699	Negative		34.3		12							No																														21701	Yes					21701					21																						Not Done							0	96.6									31043	1961-11-09
follow_up	ARDaC-AlcHepNet	31043_clinical_3	31043_clinical	31043_clinical_demographic	3												36.2		9							No																															No					21704					18																													3	101.8									31043	1961-11-09
follow_up	ARDaC-AlcHepNet	31043_clinical_7	31043_clinical	31043_clinical_demographic	7												37		8							No																															No					21712					11																													7	104									31043	1961-11-09
follow_up	ARDaC-AlcHepNet	31043_clinical_14	31043_clinical	31043_clinical_demographic	14												36.3		8							No																															No					21715					14																													14	102.1									31043	1961-11-09
follow_up	ARDaC-AlcHepNet	31043_clinical_28	31043_clinical	31043_clinical_demographic	28														6							No																															No					21729					10																													28	102									31043	1961-11-09
follow_up	ARDaC-AlcHepNet	31043_clinical_60	31043_clinical	31043_clinical_demographic	60												35.6		7							No																															No					21764					10																1	6												60	100									31043	1961-11-09
follow_up	ARDaC-AlcHepNet	31043_clinical_180	31043_clinical	31043_clinical_demographic	180												34.5		6							No																															No					21890					10																1													180	105.6									31043	1961-11-09
follow_up	ARDaC-AlcHepNet	31044_clinical_0	31044_clinical	31044_clinical_demographic	0																																																									14351					20																18	306												0										31044	1981-12-28
follow_up	ARDaC-AlcHepNet	31044_clinical_3	31044_clinical	31044_clinical_demographic	3												24.1		10							No																															No					14361					18																													3	70.2									31044	1981-12-28
follow_up	ARDaC-AlcHepNet	31044_clinical_7	31044_clinical	31044_clinical_demographic	7														10							No																															No					14368					18																													7	71.2									31044	1981-12-28
follow_up	ARDaC-AlcHepNet	31044_clinical_14	31044_clinical	31044_clinical_demographic	14														10							No																															No					14368					16																													14	71.2									31044	1981-12-28
follow_up	ARDaC-AlcHepNet	31044_clinical_28	31044_clinical	31044_clinical_demographic	28												22.9		7																																											14382					13																0	0												28	66.3									31044	1981-12-28
follow_up	ARDaC-AlcHepNet	31047_clinical_0	31047_clinical	31047_clinical_demographic	0			Negative	11640					11629	Negative		27		12							No																														11648	Yes					11648					32																11	77					Not Done							0	80.4									31047	1989-06-13
follow_up	ARDaC-AlcHepNet	31047_clinical_3	31047_clinical	31047_clinical_demographic	3												28.6		11							No																															No					11652					26																													3	85.4									31047	1989-06-13
follow_up	ARDaC-AlcHepNet	31049_clinical_0	31049_clinical	31049_clinical_demographic	0			Negative	15883				No				27.7		11							No																														15886	Yes					15886					31																						Not Done							0	90.2									31049	1977-12-04
follow_up	ARDaC-AlcHepNet	31049_clinical_3	31049_clinical	31049_clinical_demographic	3														10							No																															No					15888					30																													3										31049	1977-12-04
follow_up	ARDaC-AlcHepNet	31049_clinical_7	31049_clinical	31049_clinical_demographic	7														11							No																															No					15892					29																													7										31049	1977-12-04
follow_up	ARDaC-AlcHepNet	31049_clinical_14	31049_clinical	31049_clinical_demographic	14												27.4		11																																											15901					50																													14	89									31049	1977-12-04
follow_up	ARDaC-AlcHepNet	31050_clinical_0	31050_clinical	31050_clinical_demographic	0		Not Done							17981	Negative		26.7		11							No																														17981	Yes					17980					22																21	275						17981			Negative			0	82									31050	1972-03-23
follow_up	ARDaC-AlcHepNet	31051_clinical_0	31051_clinical	31051_clinical_demographic	0			Negative	15504					15502	Negative		28.9		10							No																														15502	Yes					15508					23																15	170						15502			Negative			0	88.64									31051	1978-12-30
follow_up	ARDaC-AlcHepNet	31058_clinical_0	31058_clinical	31058_clinical_demographic	0			Negative	15917					15917	Positive	Psychrobacter species (sanguinis)	37.2		10							No																														15917	Yes					15920					24																						Not Done							0	104.55									31058	1978-01-21
follow_up	ARDaC-AlcHepNet	31058_clinical_3	31058_clinical	31058_clinical_demographic	3												35.76		10																																											15923					24																													3	100.5									31058	1978-01-21
follow_up	ARDaC-AlcHepNet	31058_clinical_14	31058_clinical	31058_clinical_demographic	14												36.02		10																																											15930					25																													14	104									31058	1978-01-21
follow_up	ARDaC-AlcHepNet	31058_clinical_28	31058_clinical	31058_clinical_demographic	28												35.99		10																																											15951					24																0	0												28	101									31058	1978-01-21
follow_up	ARDaC-AlcHepNet	31058_clinical_60	31058_clinical	31058_clinical_demographic	60												31.95																																																																		0	0												60	92.5									31058	1978-01-21
follow_up	ARDaC-AlcHepNet	31058_clinical_90	31058_clinical	31058_clinical_demographic	90												31.95		9							No																															No					16008					15																0	0												90	92.5									31058	1978-01-21
follow_up	ARDaC-AlcHepNet	31058_clinical_180	31058_clinical	31058_clinical_demographic	180														6																																											16098					12																0	0												180										31058	1978-01-21
follow_up	ARDaC-AlcHepNet	31062_clinical_0	31062_clinical	31062_clinical_demographic	0		Not Done							16169	Negative		28.3		10							Yes																														16169	Yes					16171					20																						Not Done							0	81.82									31062	1977-06-09
follow_up	ARDaC-AlcHepNet	31064_clinical_0	31064_clinical	31064_clinical_demographic	0		Not Done							17864	Negative		24.8		9							No																														17864	Yes					17866					21																21	77						17865			Negative			0	66									31064	1972-11-14
follow_up	ARDaC-AlcHepNet	31064_clinical_7	31064_clinical	31064_clinical_demographic	7												24.03		7																																											17873					19																													7	63.5									31064	1972-11-14
follow_up	ARDaC-AlcHepNet	31064_clinical_180	31064_clinical	31064_clinical_demographic	180			Missing									32.5		12							No																														18039	Yes										23																0	0					Not Done							180	85.91									31064	1972-11-14
follow_up	ARDaC-AlcHepNet	31068_clinical_0	31068_clinical	31068_clinical_demographic	0												46.1		9							No																															No					18114					20																0	0												0	158									31068	1972-04-26
follow_up	ARDaC-AlcHepNet	31068_clinical_3	31068_clinical	31068_clinical_demographic	3												47.8		9							No																															No					18118					19																													3	164.8									31068	1972-04-26
follow_up	ARDaC-AlcHepNet	31068_clinical_7	31068_clinical	31068_clinical_demographic	7												47.9		9																																											18121					18																													7	164.8									31068	1972-04-26
follow_up	ARDaC-AlcHepNet	31068_clinical_14	31068_clinical	31068_clinical_demographic	14		Not Done							18131	Positive	Pseudomonas aeruginosa	47.8		11							No																														18130	Yes					18131					26																							18130	No; Positive for other organisms only	Enterococcus faecium	Positive			14	164.8									31068	1972-04-26
follow_up	ARDaC-AlcHepNet	31071_clinical_0	31071_clinical	31071_clinical_demographic	0			Negative	21644					21644	Negative		17		11							No																														21638	Yes					21641					22																0	0					Not Done							0	56.5									31071	1962-09-09
follow_up	ARDaC-AlcHepNet	31074_clinical_0	31074_clinical	31074_clinical_demographic	0			Negative	20344					20340	Negative		28.4		10							No																														20322	Yes					20325					23																27	270						20341			Negative			0	72.73									31074	1966-05-15
follow_up	ARDaC-AlcHepNet	31074_clinical_14	31074_clinical	31074_clinical_demographic	14												21.1		9																																											20340					27																													14	54									31074	1966-05-15
follow_up	ARDaC-AlcHepNet	31074_clinical_28	31074_clinical	31074_clinical_demographic	28			Negative	20350					20352	Negative		21.1		12							No																														20347	Yes					20352					26																							20342			Negative			28	54									31074	1966-05-15
follow_up	ARDaC-AlcHepNet	31074_clinical_90	31074_clinical	31074_clinical_demographic	90												20.44		9																																																14																0	0												90	52.3									31074	1966-05-15
follow_up	ARDaC-AlcHepNet	31077_clinical_0	31077_clinical	31077_clinical_demographic	0			Negative	20982					20981	Negative				11							No																														20975	Yes					20982					35																10	340						20977			Negative			0	91.4									31077	1964-08-16
follow_up	ARDaC-AlcHepNet	31077_clinical_3	31077_clinical	31077_clinical_demographic	3			Negative	20983					20981	Negative		29.2		13							No																														20975	Yes					20987					33																							20977			Negative			3	97.73									31077	1964-08-16
follow_up	ARDaC-AlcHepNet	31077_clinical_7	31077_clinical	31077_clinical_demographic	7												29.2		11																																											20989					32																													7	97.73									31077	1964-08-16
follow_up	ARDaC-AlcHepNet	31077_clinical_14	31077_clinical	31077_clinical_demographic	14												29.2		12																																											20997					40																													14	97.73									31077	1964-08-16
follow_up	ARDaC-AlcHepNet	31079_clinical_0	31079_clinical	31079_clinical_demographic	0			Negative	19009					19003	Negative				9							No																														18998	Yes					19007					21																0	0						19000			Negative			0	93.8									31079	1970-01-15
follow_up	ARDaC-AlcHepNet	31079_clinical_3	31079_clinical	31079_clinical_demographic	3												24.8		11							No																															No					19010					21																													3	90									31079	1970-01-15
follow_up	ARDaC-AlcHepNet	31079_clinical_7	31079_clinical	31079_clinical_demographic	7												24.8		10																																											19016					20																													7	90									31079	1970-01-15
follow_up	ARDaC-AlcHepNet	31079_clinical_14	31079_clinical	31079_clinical_demographic	14												24.8		11																																											19019					21																													14	90									31079	1970-01-15
follow_up	ARDaC-AlcHepNet	31079_clinical_28	31079_clinical	31079_clinical_demographic	28												24.8		10																																											19031					20																0	0												28	90									31079	1970-01-15
follow_up	ARDaC-AlcHepNet	42015_clinical_0	42015_clinical	42015_clinical_demographic	0		Not Done							22754	Negative		29.2		8							No																														22754	Yes					22758					21																27	324					Not Done							0	94.8									42015	1958-11-18
follow_up	ARDaC-AlcHepNet	42015_clinical_3	42015_clinical	42015_clinical_demographic	3												29.3		8																																											22760					17																													3	95.4									42015	1958-11-18
follow_up	ARDaC-AlcHepNet	42015_clinical_7	42015_clinical	42015_clinical_demographic	7												30.3		8							No																															No					22765					13																													7	98.4									42015	1958-11-18
follow_up	ARDaC-AlcHepNet	42015_clinical_14	42015_clinical	42015_clinical_demographic	14												30.3		7							No																															No					22772					11																14	117												14	98.4									42015	1958-11-18
follow_up	ARDaC-AlcHepNet	42015_clinical_28	42015_clinical	42015_clinical_demographic	28												31.2		5							No																															No					22786					8																0	0												28	101.6									42015	1958-11-18
follow_up	ARDaC-AlcHepNet	42015_clinical_60	42015_clinical	42015_clinical_demographic	60														5																																											22828					7																0	0												60	106.1									42015	1958-11-18
follow_up	ARDaC-AlcHepNet	42015_clinical_90	42015_clinical	42015_clinical_demographic	90																																																									22870					7																0	0												90	107									42015	1958-11-18
follow_up	ARDaC-AlcHepNet	42020_clinical_0	42020_clinical	42020_clinical_demographic	0			Negative	18588					18585	Negative		24.5		13							Yes	18587																													18587	Yes					18587					27																							18585			Negative			0	60.7									42020	1970-06-16
follow_up	ARDaC-AlcHepNet	42021_clinical_0	42021_clinical	42021_clinical_demographic	0		Not Done							12395	Negative				9							No																														12399	Yes					12399					20																						Not Done							0	67.4									42021	1987-05-26
follow_up	ARDaC-AlcHepNet	42021_clinical_3	42021_clinical	42021_clinical_demographic	3		Not Done							12402	Negative											No																														12403	Yes					12403					18																						Not Done							3										42021	1987-05-26
follow_up	ARDaC-AlcHepNet	42021_clinical_7	42021_clinical	42021_clinical_demographic	7														8																																											12406					18																													7	66.1									42021	1987-05-26
follow_up	ARDaC-AlcHepNet	42021_clinical_14	42021_clinical	42021_clinical_demographic	14														8																																											12417					19																													14	60.2									42021	1987-05-26
follow_up	ARDaC-AlcHepNet	42021_clinical_28	42021_clinical	42021_clinical_demographic	28														8							No																															No					12431					19																													28	57.2									42021	1987-05-26
follow_up	ARDaC-AlcHepNet	42021_clinical_60	42021_clinical	42021_clinical_demographic	60																																																																														0	0												60										42021	1987-05-26
follow_up	ARDaC-AlcHepNet	42022_clinical_0	42022_clinical	42022_clinical_demographic	0		Not Done							14360	Negative		39		10							Yes						No	Large																							14365	Yes					14365					26																	90					Not Done							0	96.7									42022	1982-02-08
follow_up	ARDaC-AlcHepNet	42022_clinical_3	42022_clinical	42022_clinical_demographic	3														10																																											14368					29																													3										42022	1982-02-08
follow_up	ARDaC-AlcHepNet	42022_clinical_7	42022_clinical	42022_clinical_demographic	7														11																																											14373					31																													7	96.1									42022	1982-02-08
follow_up	ARDaC-AlcHepNet	42023_clinical_0	42023_clinical	42023_clinical_demographic	0			Negative	21080					21075	Negative		24		11							Yes						No	Small																							21080	Yes					21080					21										Yes, Mild													21068			Negative			0	63.5									42023	1963-09-29
follow_up	ARDaC-AlcHepNet	42026_clinical_0	42026_clinical	42026_clinical_demographic	0		Not Done							16788	Negative				9							Yes						No	Small											No	Small											16791	Yes					16791					24										Yes, Mild						18	180					Not Done							0	129.5									42026	1975-07-27
follow_up	ARDaC-AlcHepNet	42026_clinical_3	42026_clinical	42026_clinical_demographic	3														9																																											16794					28																													3	131.1									42026	1975-07-27
follow_up	ARDaC-AlcHepNet	42026_clinical_7	42026_clinical	42026_clinical_demographic	7														9																																											16798					34																													7	133.8									42026	1975-07-27
follow_up	ARDaC-AlcHepNet	42026_clinical_14	42026_clinical	42026_clinical_demographic	14																																																									16805																																		14										42026	1975-07-27
follow_up	ARDaC-AlcHepNet	42027_clinical_0	42027_clinical	42027_clinical_demographic	0		Not Done						No				23.9		10							Yes																														14858	Yes					14858					24										Yes, Mild													14855			Negative			0	65.1									42027	1980-11-10
follow_up	ARDaC-AlcHepNet	42027_clinical_3	42027_clinical	42027_clinical_demographic	3														10																																											14861					21																													3										42027	1980-11-10
follow_up	ARDaC-AlcHepNet	42027_clinical_7	42027_clinical	42027_clinical_demographic	7														9																																											14863					19																													7										42027	1980-11-10
follow_up	ARDaC-AlcHepNet	42027_clinical_14	42027_clinical	42027_clinical_demographic	14														8																																											14870					15																													14	68.4									42027	1980-11-10
follow_up	ARDaC-AlcHepNet	42027_clinical_28	42027_clinical	42027_clinical_demographic	28														6																																											14889					10																0	1												28	65.2									42027	1980-11-10
follow_up	ARDaC-AlcHepNet	42027_clinical_60	42027_clinical	42027_clinical_demographic	60												25.3		5																																											14924					7																1	0												60	68.9									42027	1980-11-10
follow_up	ARDaC-AlcHepNet	42027_clinical_180	42027_clinical	42027_clinical_demographic	180																																																																															3												180										42027	1980-11-10
follow_up	ARDaC-AlcHepNet	42028_clinical_0	42028_clinical	42028_clinical_demographic	0		Not Done							13216	Negative				10							Yes	13220					No	Medium																							13221	Yes					13221					26										Yes, Mild						5	12						13215			Negative			0	118.1									42028	1985-06-16
follow_up	ARDaC-AlcHepNet	42028_clinical_3	42028_clinical	42028_clinical_demographic	3														10																																											13224					25																													3	118.7									42028	1985-06-16
follow_up	ARDaC-AlcHepNet	42028_clinical_7	42028_clinical	42028_clinical_demographic	7												33.2		9																																											13226					24																													7	120.5									42028	1985-06-16
follow_up	ARDaC-AlcHepNet	42028_clinical_90	42028_clinical	42028_clinical_demographic	90		Not Done							13313	Negative				10							No																														13317	Yes					13317					46																							13313	No; Positive for other organisms only	staph. aureus	Positive			90										42028	1985-06-16
follow_up	ARDaC-AlcHepNet	42033_clinical_0	42033_clinical	42033_clinical_demographic	0			Negative	15621					15621	Negative				12							No																														15626	Yes					15626					21																							15621	No; Positive for other organisms only	E.coli	Positive			0	69.31									42033	1979-04-17
follow_up	ARDaC-AlcHepNet	42033_clinical_3	42033_clinical	42033_clinical_demographic	3														10																																											15629					18																													3	68.4									42033	1979-04-17
follow_up	ARDaC-AlcHepNet	42033_clinical_7	42033_clinical	42033_clinical_demographic	7														11							No																															No					15632					16																													7	66.2									42033	1979-04-17
follow_up	ARDaC-AlcHepNet	42033_clinical_14	42033_clinical	42033_clinical_demographic	14														7																																											15640					15																													14	61.59									42033	1979-04-17
follow_up	ARDaC-AlcHepNet	42033_clinical_28	42033_clinical	42033_clinical_demographic	28		Not Done						No						6							No																														15653	Yes					15653					12																	0						15653			Negative			28	63.7									42033	1979-04-17
follow_up	ARDaC-AlcHepNet	42033_clinical_60	42033_clinical	42033_clinical_demographic	60												21.1		7							No																															No										14																0	0												60	63.04									42033	1979-04-17
follow_up	ARDaC-AlcHepNet	42033_clinical_90	42033_clinical	42033_clinical_demographic	90												22		6							No																															No										13																													90	145									42033	1979-04-17
follow_up	ARDaC-AlcHepNet	42033_clinical_180	42033_clinical	42033_clinical_demographic	180												22		8																																											15814					23																1	1												180	145									42033	1979-04-17
follow_up	ARDaC-AlcHepNet	51054_clinical_0	51054_clinical	51054_clinical_demographic	0		Not Done							11076	Negative		23.5		11							No																														11076	Yes					11083					26																17	85						11076			Negative			0	58.2									51054	1990-04-09
follow_up	ARDaC-AlcHepNet	51057_clinical_0	51057_clinical	51057_clinical_demographic	0												27.7		11							No																															No					12951					20																													0	84.5									51057	1985-03-09
follow_up	ARDaC-AlcHepNet	51057_clinical_3	51057_clinical	51057_clinical_demographic	3												25.6		10																																											12953					20																													3	78									51057	1985-03-09
follow_up	ARDaC-AlcHepNet	51057_clinical_7	51057_clinical	51057_clinical_demographic	7														9																																											12956					19																													7	75.9									51057	1985-03-09
follow_up	ARDaC-AlcHepNet	51057_clinical_14	51057_clinical	51057_clinical_demographic	14														8																																											12963					18																													14	74.4									51057	1985-03-09
follow_up	ARDaC-AlcHepNet	51058_clinical_0	51058_clinical	51058_clinical_demographic	0												27.2		12																																											16120					30																													0	61.3									51058	1976-07-17
follow_up	ARDaC-AlcHepNet	51058_clinical_3	51058_clinical	51058_clinical_demographic	3														12																																											16124					33																													3										51058	1976-07-17
follow_up	ARDaC-AlcHepNet	51058_clinical_7	51058_clinical	51058_clinical_demographic	7														12							Yes	16129			Yes	Small	Yes	Small																								No					16127					32																													7										51058	1976-07-17
follow_up	ARDaC-AlcHepNet	51062_clinical_0	51062_clinical	51062_clinical_demographic	0												27		11																																											18279					24																16	176												0	84.4									51062	1970-10-22
follow_up	ARDaC-AlcHepNet	51062_clinical_3	51062_clinical	51062_clinical_demographic	3																																																																																											3	85.2									51062	1970-10-22
follow_up	ARDaC-AlcHepNet	51062_clinical_7	51062_clinical	51062_clinical_demographic	7														9																																											18285					25																													7	84.8									51062	1970-10-22
follow_up	ARDaC-AlcHepNet	51062_clinical_60	51062_clinical	51062_clinical_demographic	60																																																																																											60	80.2									51062	1970-10-22
follow_up	ARDaC-AlcHepNet	51062_clinical_90	51062_clinical	51062_clinical_demographic	90												23.5																																																																		0	0												90	74.8									51062	1970-10-22
follow_up	ARDaC-AlcHepNet	51062_clinical_180	51062_clinical	51062_clinical_demographic	180														6																																											18457					12																0	0												180	76.9									51062	1970-10-22
follow_up	ARDaC-AlcHepNet	51063_clinical_0	51063_clinical	51063_clinical_demographic	0														11																																											22332					31																													0	85									51063	1959-09-27
follow_up	ARDaC-AlcHepNet	51063_clinical_3	51063_clinical	51063_clinical_demographic	3														10																																											22700					29																													3										51063	1959-09-27
follow_up	ARDaC-AlcHepNet	51063_clinical_7	51063_clinical	51063_clinical_demographic	7																																																									22338					27																													7										51063	1959-09-27
follow_up	ARDaC-AlcHepNet	51063_clinical_14	51063_clinical	51063_clinical_demographic	14																																																																																											14	83.4									51063	1959-09-27
follow_up	ARDaC-AlcHepNet	51063_clinical_28	51063_clinical	51063_clinical_demographic	28																																																																																											28	84.4									51063	1959-09-27
follow_up	ARDaC-AlcHepNet	51063_clinical_60	51063_clinical	51063_clinical_demographic	60																					No																															No																																							60	73.3									51063	1959-09-27
follow_up	ARDaC-AlcHepNet	51063_clinical_90	51063_clinical	51063_clinical_demographic	90																																																																														0	0												90	75.4									51063	1959-09-27
follow_up	ARDaC-AlcHepNet	51063_clinical_180	51063_clinical	51063_clinical_demographic	180														5							No																															No					22515					11																0	0												180	82.2									51063	1959-09-27
follow_up	ARDaC-AlcHepNet	51069_clinical_0	51069_clinical	51069_clinical_demographic	0														12																																											14637					28																													0										51069	1980-12-23
follow_up	ARDaC-AlcHepNet	51069_clinical_3	51069_clinical	51069_clinical_demographic	3												31.4		10							No																															No										25																													3	94									51069	1980-12-23
follow_up	ARDaC-AlcHepNet	51069_clinical_7	51069_clinical	51069_clinical_demographic	7												30.7		11																																											14644					23																													7	92									51069	1980-12-23
follow_up	ARDaC-AlcHepNet	51069_clinical_14	51069_clinical	51069_clinical_demographic	14														10																																																17																													14	87.6									51069	1980-12-23
follow_up	ARDaC-AlcHepNet	51069_clinical_28	51069_clinical	51069_clinical_demographic	28														8																																																13																													28	93.3									51069	1980-12-23
follow_up	ARDaC-AlcHepNet	51069_clinical_60	51069_clinical	51069_clinical_demographic	60														7																																											14695					9																0	0												60	93.4									51069	1980-12-23
follow_up	ARDaC-AlcHepNet	51069_clinical_90	51069_clinical	51069_clinical_demographic	90														7																																											14722					9																0	0												90	82									51069	1980-12-23
follow_up	ARDaC-AlcHepNet	51069_clinical_180	51069_clinical	51069_clinical_demographic	180														5																																											14827					7																0	0												180	74.8									51069	1980-12-23
follow_up	ARDaC-AlcHepNet	51073_clinical_0	51073_clinical	51073_clinical_demographic	0												26.4		11							No																															No					16790					28																24	384												0	93.2									51073	1975-03-12
follow_up	ARDaC-AlcHepNet	51080_clinical_0	51080_clinical	51080_clinical_demographic	0														11							No																															No					11616					25																27	216												0										51080	1989-08-08
follow_up	ARDaC-AlcHepNet	51080_clinical_3	51080_clinical	51080_clinical_demographic	3														12																																											11619					27																													3										51080	1989-08-08
follow_up	ARDaC-AlcHepNet	51080_clinical_7	51080_clinical	51080_clinical_demographic	7														12																																											11622					27																													7										51080	1989-08-08
follow_up	ARDaC-AlcHepNet	51080_clinical_14	51080_clinical	51080_clinical_demographic	14														13																																											11628					29																													14	96.1									51080	1989-08-08
follow_up	ARDaC-AlcHepNet	51080_clinical_28	51080_clinical	51080_clinical_demographic	28												34.5		12																																											11642					22																0	0												28	99.6									51080	1989-08-08
follow_up	ARDaC-AlcHepNet	51088_clinical_0	51088_clinical	51088_clinical_demographic	0														13							No																															No					20747					24																27	216												0										51088	1964-09-23
follow_up	ARDaC-AlcHepNet	51088_clinical_3	51088_clinical	51088_clinical_demographic	3																																																									20749																																		3										51088	1964-09-23
follow_up	ARDaC-AlcHepNet	51098_clinical_0	51098_clinical	51098_clinical_demographic	0			Negative	22406					22405	Negative				10							No																														22405	Yes					22410					27																10	50						22405			Negative			0										51098	1960-05-21
follow_up	ARDaC-AlcHepNet	51098_clinical_3	51098_clinical	51098_clinical_demographic	3														8																																											22413					25																													3	143									51098	1960-05-21
follow_up	ARDaC-AlcHepNet	51098_clinical_7	51098_clinical	51098_clinical_demographic	7														9																																											22417					24																													7	137									51098	1960-05-21
follow_up	ARDaC-AlcHepNet	51098_clinical_14	51098_clinical	51098_clinical_demographic	14														9																																											22424					19																													14	132									51098	1960-05-21
follow_up	ARDaC-AlcHepNet	51098_clinical_28	51098_clinical	51098_clinical_demographic	28														8																																											22444					13																0	0												28	131									51098	1960-05-21
follow_up	ARDaC-AlcHepNet	51098_clinical_60	51098_clinical	51098_clinical_demographic	60														6																																											22479					10																0	0												60	134									51098	1960-05-21
follow_up	ARDaC-AlcHepNet	51100_clinical_0	51100_clinical	51100_clinical_demographic	0														11							No																															No					18083					25																26	208												0										51100	1972-04-19
follow_up	ARDaC-AlcHepNet	51100_clinical_3	51100_clinical	51100_clinical_demographic	3														10																																											18086					25																													3										51100	1972-04-19
follow_up	ARDaC-AlcHepNet	51100_clinical_7	51100_clinical	51100_clinical_demographic	7														9																																											18090					19																													7	91.2									51100	1972-04-19
follow_up	ARDaC-AlcHepNet	51100_clinical_14	51100_clinical	51100_clinical_demographic	14														9																																											18097					17																													14	85.9									51100	1972-04-19
follow_up	ARDaC-AlcHepNet	51100_clinical_28	51100_clinical	51100_clinical_demographic	28														8																																											18116					11																0	0												28	80.9									51100	1972-04-19
follow_up	ARDaC-AlcHepNet	51100_clinical_60	51100_clinical	51100_clinical_demographic	60														6																																											18172					9																0	0												60	77.2									51100	1972-04-19
follow_up	ARDaC-AlcHepNet	51100_clinical_90	51100_clinical	51100_clinical_demographic	90														5																																											18200					9																0	0												90	77.6									51100	1972-04-19
follow_up	ARDaC-AlcHepNet	51100_clinical_180	51100_clinical	51100_clinical_demographic	180														5																																																8																0	0												180	79.4									51100	1972-04-19
follow_up	ARDaC-AlcHepNet	52001_clinical_0	52001_clinical	52001_clinical_demographic	0			Negative	16059					16058	Negative		28.3		9							No																														16058	Yes					16060					22																27	158					Not Done							0	74.9									52001	1976-11-10
follow_up	ARDaC-AlcHepNet	52001_clinical_3	52001_clinical	52001_clinical_demographic	3												26.6		11																																											16063					23																													3	73.3									52001	1976-11-10
follow_up	ARDaC-AlcHepNet	52003_clinical_0	52003_clinical	52003_clinical_demographic	0												28.7		11																																											13972					28																26	442												0	96									52003	1982-10-19
follow_up	ARDaC-AlcHepNet	52003_clinical_3	52003_clinical	52003_clinical_demographic	3												30.5		9																																											13974					29																													3	102									52003	1982-10-19
follow_up	ARDaC-AlcHepNet	52003_clinical_7	52003_clinical	52003_clinical_demographic	7												29		8																																											13979					22																													7	97.1									52003	1982-10-19
follow_up	ARDaC-AlcHepNet	52003_clinical_14	52003_clinical	52003_clinical_demographic	14												28.6		8							No																															No					13986					16																12	204												14	95.6									52003	1982-10-19
follow_up	ARDaC-AlcHepNet	52003_clinical_28	52003_clinical	52003_clinical_demographic	28												28.6		7							No																															No					14000					15																0	0												28	95.6									52003	1982-10-19
follow_up	ARDaC-AlcHepNet	52003_clinical_60	52003_clinical	52003_clinical_demographic	60																																																									14027																																		60										52003	1982-10-19
follow_up	ARDaC-AlcHepNet	52004_clinical_0	52004_clinical	52004_clinical_demographic	0		Not Done							9989	Negative		38.6		10							No																														9989	Yes					9991					26																0	0						9990	No; Positive for other organisms only	mixed gram positive organisms	Positive			0	122									52004	1993-11-08
follow_up	ARDaC-AlcHepNet	52004_clinical_3	52004_clinical	52004_clinical_demographic	3												39.1		10							Yes	9992																														No					9992					26																													3	124									52004	1993-11-08
follow_up	ARDaC-AlcHepNet	52004_clinical_7	52004_clinical	52004_clinical_demographic	7												39.1		8							Yes																															No					9996					22																													7	124									52004	1993-11-08
follow_up	ARDaC-AlcHepNet	52004_clinical_14	52004_clinical	52004_clinical_demographic	14														9							No																															No					10003					21																0	0												14										52004	1993-11-08
follow_up	ARDaC-AlcHepNet	52004_clinical_28	52004_clinical	52004_clinical_demographic	28												34.3		8							No																															No					10017					16																0	0												28	108									52004	1993-11-08
follow_up	ARDaC-AlcHepNet	52004_clinical_60	52004_clinical	52004_clinical_demographic	60												34.7		6							No																															No					10045					12																0	0												60	110									52004	1993-11-08
follow_up	ARDaC-AlcHepNet	52004_clinical_90	52004_clinical	52004_clinical_demographic	90												33.9		6							No																															No					10073					8																0	0												90	107									52004	1993-11-08
follow_up	ARDaC-AlcHepNet	52004_clinical_180	52004_clinical	52004_clinical_demographic	180														5							No																															No					10171					7																0	0												180	113.8									52004	1993-11-08
follow_up	ARDaC-AlcHepNet	52005_clinical_0	52005_clinical	52005_clinical_demographic	0														10																																											15842					26																													0										52005	1977-11-28
follow_up	ARDaC-AlcHepNet	52005_clinical_3	52005_clinical	52005_clinical_demographic	3												24.6		10																																											15845					28																													3	84.4									52005	1977-11-28
follow_up	ARDaC-AlcHepNet	52005_clinical_7	52005_clinical	52005_clinical_demographic	7			Negative	15848				No						10							Yes	15850					Yes	Large											No	Small											15852	Yes					15852					34										Yes, Mild												Not Done							7										52005	1977-11-28
follow_up	ARDaC-AlcHepNet	52006_clinical_0	52006_clinical	52006_clinical_demographic	0		Not Done							13888	Negative		27.5		11							No																														13888	Yes					13890					24																28	270						13888			Negative			0	79.5									52006	1983-04-26
follow_up	ARDaC-AlcHepNet	52006_clinical_3	52006_clinical	52006_clinical_demographic	3												28.7		9							No																															No					13894					23																													3	83.3									52006	1983-04-26
follow_up	ARDaC-AlcHepNet	52006_clinical_7	52006_clinical	52006_clinical_demographic	7														9							No																															No					13898					22																													7	80.6									52006	1983-04-26
follow_up	ARDaC-AlcHepNet	52006_clinical_14	52006_clinical	52006_clinical_demographic	14												26.6		9							No																															No					13904					22																													14	77.1									52006	1983-04-26
follow_up	ARDaC-AlcHepNet	52006_clinical_28	52006_clinical	52006_clinical_demographic	28												25.5		6							No																															No					13923					15																0	0												28	73.9									52006	1983-04-26
follow_up	ARDaC-AlcHepNet	52006_clinical_60	52006_clinical	52006_clinical_demographic	60												25.2		5							No																															No					13954					12																0	0												60	72.9									52006	1983-04-26
follow_up	ARDaC-AlcHepNet	52006_clinical_90	52006_clinical	52006_clinical_demographic	90												23.3		6							No																															No					14023					15																30	285												90	69.3									52006	1983-04-26
follow_up	ARDaC-AlcHepNet	52007_clinical_0	52007_clinical	52007_clinical_demographic	0												35.7		10							No																															No					10511					27																													0	93.2									52007	1993-01-25
follow_up	ARDaC-AlcHepNet	52007_clinical_3	52007_clinical	52007_clinical_demographic	3												35.7		11							Yes	10511																														No					10513					26										Yes, Moderate																			3	93.2									52007	1993-01-25
follow_up	ARDaC-AlcHepNet	53003_clinical_0	53003_clinical	53003_clinical_demographic	0			Negative	17080					17080	Negative		34.48		12							No																														17080	Yes					17081					34																0	0						17080			Negative			0										53003	1974-08-29
follow_up	ARDaC-AlcHepNet	53003_clinical_3	53003_clinical	53003_clinical_demographic	3																																																									17086					28																													3										53003	1974-08-29
follow_up	ARDaC-AlcHepNet	53003_clinical_7	53003_clinical	53003_clinical_demographic	7												33.3		8							No																															No					17092					23																													7	103									53003	1974-08-29
follow_up	ARDaC-AlcHepNet	53003_clinical_14	53003_clinical	53003_clinical_demographic	14		Not Done						No													No																														17098	Yes					17098					24																							17098			Negative			14										53003	1974-08-29
follow_up	ARDaC-AlcHepNet	53003_clinical_28	53003_clinical	53003_clinical_demographic	28												31.04									No																															No					17113					23																0	0												28	95.4									53003	1974-08-29
follow_up	ARDaC-AlcHepNet	53003_clinical_60	53003_clinical	53003_clinical_demographic	60												28.57																																													17150					15																0	0												60	87.8									53003	1974-08-29
follow_up	ARDaC-AlcHepNet	53003_clinical_90	53003_clinical	53003_clinical_demographic	90																																																																														0	0												90										53003	1974-08-29
follow_up	ARDaC-AlcHepNet	53003_clinical_180	53003_clinical	53003_clinical_demographic	180												29.43																																													17259					11																0	0												180	90.4									53003	1974-08-29
follow_up	ARDaC-AlcHepNet	53004_clinical_0	53004_clinical	53004_clinical_demographic	0												32.63																																													13149					23																0	0												0	91.7									53004	1985-06-10
follow_up	ARDaC-AlcHepNet	53004_clinical_3	53004_clinical	53004_clinical_demographic	3												34.76																																													13153					27																													3	97.7									53004	1985-06-10
follow_up	ARDaC-AlcHepNet	53004_clinical_7	53004_clinical	53004_clinical_demographic	7												34.4		10							No																															No					13157					28.3																													7	96.8									53004	1985-06-10
follow_up	ARDaC-AlcHepNet	53004_clinical_14	53004_clinical	53004_clinical_demographic	14												34.5									No																															No					13164					37																													14	96.9									53004	1985-06-10
follow_up	ARDaC-AlcHepNet	53004_clinical_28	53004_clinical	53004_clinical_demographic	28												33.3																																													13175					30																0	0												28										53004	1985-06-10
follow_up	ARDaC-AlcHepNet	53004_clinical_60	53004_clinical	53004_clinical_demographic	60												28.2																																													13212					14																0	0												60	79.2									53004	1985-06-10
follow_up	ARDaC-AlcHepNet	53004_clinical_90	53004_clinical	53004_clinical_demographic	90																																																																														0	0												90										53004	1985-06-10
follow_up	ARDaC-AlcHepNet	53004_clinical_180	53004_clinical	53004_clinical_demographic	180												28.15									No																															No					13321					12																0	0												180	79.1									53004	1985-06-10
follow_up	ARDaC-AlcHepNet	61037_clinical_0	61037_clinical	61037_clinical_demographic	0		Not Done							12531	Negative		27.2		7							No																														12531	Yes					12534					22																							12532			Negative			0	91.2									61037	1986-05-23
follow_up	ARDaC-AlcHepNet	61037_clinical_3	61037_clinical	61037_clinical_demographic	3												26.5		8																																											12537					24																													3	88.5									61037	1986-05-23
follow_up	ARDaC-AlcHepNet	61037_clinical_7	61037_clinical	61037_clinical_demographic	7												26.5		7																																											12543					23																													7	88.5									61037	1986-05-23
follow_up	ARDaC-AlcHepNet	61037_clinical_14	61037_clinical	61037_clinical_demographic	14		Not Done							12544	Negative		26.4		6							No																														12544	Yes					12550					19																9	76					Not Done							14	88.5									61037	1986-05-23
follow_up	ARDaC-AlcHepNet	61037_clinical_28	61037_clinical	61037_clinical_demographic	28												26.4		8																																											12564					14																													28	88.2									61037	1986-05-23
follow_up	ARDaC-AlcHepNet	61037_clinical_60	61037_clinical	61037_clinical_demographic	60												26.4		5																																											12592					10																0	0												60	88.4									61037	1986-05-23
follow_up	ARDaC-AlcHepNet	61037_clinical_90	61037_clinical	61037_clinical_demographic	90												26.4		5																																											12620					7																0	0												90	88.5									61037	1986-05-23
follow_up	ARDaC-AlcHepNet	61037_clinical_180	61037_clinical	61037_clinical_demographic	180												62.1		5																																											12711					8																0	0												180	207.6									61037	1986-05-23
follow_up	ARDaC-AlcHepNet	61038_clinical_0	61038_clinical	61038_clinical_demographic	0												23.2		8																																											17952					27																													0	73.5									61038	1971-08-07
follow_up	ARDaC-AlcHepNet	61038_clinical_3	61038_clinical	61038_clinical_demographic	3		Not Done							17955	Negative		23.2		8							No																														17955	Yes					17958					33																						Not Done							3	73.5									61038	1971-08-07
follow_up	ARDaC-AlcHepNet	61038_clinical_7	61038_clinical	61038_clinical_demographic	7		Not Done							17959	Negative		23.2		7							No																														17959	Yes					17960					37																						Not Done							7	73.5									61038	1971-08-07
follow_up	ARDaC-AlcHepNet	61038_clinical_14	61038_clinical	61038_clinical_demographic	14			Negative	17940					17966	Positive	yeast	23.2		11							No																														17966	Yes					17966					42																6	60					Not Done							14	73.5									61038	1971-08-07
follow_up	ARDaC-AlcHepNet	61038_clinical_28	61038_clinical	61038_clinical_demographic	28			Negative	17969					17971	Negative		23.2		13							No																														17971	Yes					17972					44																0	0					Not Done							28	73.5									61038	1971-08-07
follow_up	ARDaC-AlcHepNet	61039_clinical_0	61039_clinical	61039_clinical_demographic	0												23.6		7							No																															No					21537					26																													0	60.3									61039	1961-10-27
follow_up	ARDaC-AlcHepNet	61039_clinical_3	61039_clinical	61039_clinical_demographic	3												23.6		9							No																															No					21538					27																													3	60.3									61039	1961-10-27
follow_up	ARDaC-AlcHepNet	61039_clinical_7	61039_clinical	61039_clinical_demographic	7		Not Done						No				23.6		7							No																														21538	Yes					21543					26																							21538	No; Positive for other organisms only	>100,000 col/mL Klebsiella pneumoniae	Positive			7	60.3									61039	1961-10-27
follow_up	ARDaC-AlcHepNet	61039_clinical_60	61039_clinical	61039_clinical_demographic	60																																																									21623																																		60										61039	1961-10-27
follow_up	ARDaC-AlcHepNet	61039_clinical_90	61039_clinical	61039_clinical_demographic	90																																																									21634																																		90										61039	1961-10-27
follow_up	ARDaC-AlcHepNet	61039_clinical_180	61039_clinical	61039_clinical_demographic	180																																																																														0	0												180										61039	1961-10-27
follow_up	ARDaC-AlcHepNet	61045_clinical_0	61045_clinical	61045_clinical_demographic	0		Not Done							18988	Negative		25.9		10							No																														18988	Yes					18991					29																26	157					Not Done							0	77.3									61045	1969-02-05
follow_up	ARDaC-AlcHepNet	61045_clinical_3	61045_clinical	61045_clinical_demographic	3												25.9		7							No																															No					18993					29																													3	77.3									61045	1969-02-05
follow_up	ARDaC-AlcHepNet	61045_clinical_7	61045_clinical	61045_clinical_demographic	7												25.9		12																																											18997					24																													7	77.3									61045	1969-02-05
follow_up	ARDaC-AlcHepNet	61045_clinical_14	61045_clinical	61045_clinical_demographic	14												23.7		11																																											19006					18																11	55												14	70.8									61045	1969-02-05
follow_up	ARDaC-AlcHepNet	61045_clinical_28	61045_clinical	61045_clinical_demographic	28												25.1		9																																											19020					14																0	0												28	70.8									61045	1969-02-05
follow_up	ARDaC-AlcHepNet	61045_clinical_60	61045_clinical	61045_clinical_demographic	60												23.5		6							No																															No					19048					12																0	0												60	68.2									61045	1969-02-05
follow_up	ARDaC-AlcHepNet	61045_clinical_90	61045_clinical	61045_clinical_demographic	90												23.2		6																																											19069					10																0	0												90	67.5									61045	1969-02-05
follow_up	ARDaC-AlcHepNet	61046_clinical_0	61046_clinical	61046_clinical_demographic	0			Negative	13462					13461	Negative		34.1		11							No																														13461	Yes					13463					23																25	294						13461			Negative			0	114									61046	1984-04-04
follow_up	ARDaC-AlcHepNet	61046_clinical_3	61046_clinical	61046_clinical_demographic	3												34.1		12							No																															No					13465					23																													3	113.3									61046	1984-04-04
follow_up	ARDaC-AlcHepNet	61046_clinical_7	61046_clinical	61046_clinical_demographic	7												32.6		10																																											13470					20																													7	109									61046	1984-04-04
follow_up	ARDaC-AlcHepNet	61046_clinical_14	61046_clinical	61046_clinical_demographic	14												31.2		11																																											13475					18																11	126												14	104.4									61046	1984-04-04
follow_up	ARDaC-AlcHepNet	61046_clinical_28	61046_clinical	61046_clinical_demographic	28												30.8																																													13491																					0	0												28	102.9									61046	1984-04-04
follow_up	ARDaC-AlcHepNet	61046_clinical_60	61046_clinical	61046_clinical_demographic	60												30		9																																											13526					14																0	0												60	100.2									61046	1984-04-04
follow_up	ARDaC-AlcHepNet	61046_clinical_90	61046_clinical	61046_clinical_demographic	90												26.8		8																																											13554					13																0	0												90	91.4									61046	1984-04-04
follow_up	ARDaC-AlcHepNet	61046_clinical_180	61046_clinical	61046_clinical_demographic	180												29.2		8																																											13638					11																													180	95.1									61046	1984-04-04
follow_up	ARDaC-AlcHepNet	61047_clinical_0	61047_clinical	61047_clinical_demographic	0												38.7		13							No																															No					15145					29																													0	112									61047	1979-08-30
follow_up	ARDaC-AlcHepNet	61047_clinical_3	61047_clinical	61047_clinical_demographic	3		Not Done							15140	Negative		38.7		11							No																														15140	Yes					15147					30																							15140	No; Positive for other organisms only	1200 col/mL coagulase negative staph. no antimicrobial susceptibility to follow *This information was updated on 2/12 not seen until 2/17 data entry	Positive			3	112									61047	1979-08-30
follow_up	ARDaC-AlcHepNet	61047_clinical_7	61047_clinical	61047_clinical_demographic	7		Not Done							15149	Positive	Staphylococcus aureus	38.7		11							No																														15149	Yes					15153					27																						Not Done							7	112									61047	1979-08-30
follow_up	ARDaC-AlcHepNet	61047_clinical_14	61047_clinical	61047_clinical_demographic	14		Not Done							15158	Negative		38.7		12							No																														15158	Yes					15159					26																6	37						15149	No; Positive for other organisms only	> 100,000 col/ml multiple organisms probable contamination, repeat collection is recommended	Positive			14	112									61047	1979-08-30
follow_up	ARDaC-AlcHepNet	61047_clinical_28	61047_clinical	61047_clinical_demographic	28		Not Done							15158	Negative		38.7		13							Yes	15162					Yes	Large																							15158	Yes					15166					29										Missing						0	0					Not Done							28	112									61047	1979-08-30
follow_up	ARDaC-AlcHepNet	61048_clinical_0	61048_clinical	61048_clinical_demographic	0												23		11							No																															No					22803					29																													0	73									61048	1958-10-03
follow_up	ARDaC-AlcHepNet	61048_clinical_3	61048_clinical	61048_clinical_demographic	3			Negative	22804				No				23		11							No																														22804	Yes					22804					31																						Not Done							3	73.7									61048	1958-10-03
follow_up	ARDaC-AlcHepNet	61052_clinical_0	61052_clinical	61052_clinical_demographic	0												26.2		12							No																															No					20072					30																													0	64.6									61052	1966-05-17
follow_up	ARDaC-AlcHepNet	61052_clinical_3	61052_clinical	61052_clinical_demographic	3												26.2		12							No																															No					20073					30																													3	64.6									61052	1966-05-17
follow_up	ARDaC-AlcHepNet	61054_clinical_0	61054_clinical	61054_clinical_demographic	0		Not Done							11581	Negative		40.3		10							No																														11584	Yes					11584					20																26	52						11581	No; Positive for other organisms only	>100,000 col/mL Multiple Organisms, Probable contamination, repeat collection is recommended.	Positive			0	112									61054	1989-09-01
follow_up	ARDaC-AlcHepNet	61054_clinical_3	61054_clinical	61054_clinical_demographic	3		Not Done							11586	Negative		40.3		9							No																														11586	Yes					11586					30																							11585	Yes	>100,000 col/mL Yeast, not cryptococcus species	Positive			3	112									61054	1989-09-01
follow_up	ARDaC-AlcHepNet	61054_clinical_7	61054_clinical	61054_clinical_demographic	7												40.3		8							No																															No					11591					31																													7	112									61054	1989-09-01
follow_up	ARDaC-AlcHepNet	61054_clinical_28	61054_clinical	61054_clinical_demographic	28																																																									11612																																		28										61054	1989-09-01
follow_up	ARDaC-AlcHepNet	61056_clinical_0	61056_clinical	61056_clinical_demographic	0												24.1		10							No																															No					13171					20																27	189												0	65.5									61056	1985-05-18
follow_up	ARDaC-AlcHepNet	61056_clinical_3	61056_clinical	61056_clinical_demographic	3												24.1		10																																											13172					20																													3	65.5									61056	1985-05-18
follow_up	ARDaC-AlcHepNet	61056_clinical_7	61056_clinical	61056_clinical_demographic	7														10																																											13178					16																													7										61056	1985-05-18
follow_up	ARDaC-AlcHepNet	61056_clinical_60	61056_clinical	61056_clinical_demographic	60																																																																														0	0												60										61056	1985-05-18
follow_up	ARDaC-AlcHepNet	61056_clinical_180	61056_clinical	61056_clinical_demographic	180																																																									13360																																		180										61056	1985-05-18
follow_up	ARDaC-AlcHepNet	61058_clinical_0	61058_clinical	61058_clinical_demographic	0		Not Done							13922	Negative		53.7		8							No																														13922	Yes					13924					35																							13922			Negative			0	170									61058	1983-05-17
follow_up	ARDaC-AlcHepNet	61058_clinical_3	61058_clinical	61058_clinical_demographic	3												53.7		10																																											13925					35																													3	170									61058	1983-05-17
follow_up	ARDaC-AlcHepNet	61058_clinical_7	61058_clinical	61058_clinical_demographic	7		Not Done							13929	Negative		53.7									No																														13929	Yes					13931					48																							13928			Negative			7	170									61058	1983-05-17
follow_up	ARDaC-AlcHepNet	61060_clinical_0	61060_clinical	61060_clinical_demographic	0			Positive	14487		Rare WBCs present; No organisms present			14484	Negative		22.7		11							No																														14484	Yes					14488					22																19	152					Not Done							0	82.8									61060	1981-11-22
follow_up	ARDaC-AlcHepNet	61060_clinical_3	61060_clinical	61060_clinical_demographic	3												22.7		11																																											14489					22																													3	82.8									61060	1981-11-22
follow_up	ARDaC-AlcHepNet	61060_clinical_7	61060_clinical	61060_clinical_demographic	7			Positive	14487		Staphylococcus hominis No antimicrobial susceptibility to follow *contaminant			14490	Negative		22.7		10							No																														14487	Yes					14493					26																							14491	No; Positive for other organisms only	>100,000 col/mL Coagulase Negative Staph No antimicrobial susceptibility to follow *contamination	Positive			7	82.8									61060	1981-11-22
follow_up	ARDaC-AlcHepNet	61063_clinical_0	61063_clinical	61063_clinical_demographic	0		Not Done							17499	Negative		32		8							No																														17499	Yes					17501					22																25	288						17499			Negative			0	104									61063	1973-09-25
follow_up	ARDaC-AlcHepNet	61063_clinical_3	61063_clinical	61063_clinical_demographic	3												32.9		8							No																															No					17502					22																													3	104									61063	1973-09-25
follow_up	ARDaC-AlcHepNet	61063_clinical_28	61063_clinical	61063_clinical_demographic	28																																																																														0	0												28										61063	1973-09-25
follow_up	ARDaC-AlcHepNet	61063_clinical_60	61063_clinical	61063_clinical_demographic	60												33.2		5																																											17565					12																0	0												60	104.8									61063	1973-09-25
follow_up	ARDaC-AlcHepNet	61063_clinical_90	61063_clinical	61063_clinical_demographic	90																																																																														0	0												90										61063	1973-09-25
follow_up	ARDaC-AlcHepNet	61063_clinical_180	61063_clinical	61063_clinical_demographic	180																																																																														0	0												180										61063	1973-09-25
follow_up	ARDaC-AlcHepNet	61084_clinical_0	61084_clinical	61084_clinical_demographic	0												28.6		9																																											13386					21																													0	82.8									61084	1985-06-15
follow_up	ARDaC-AlcHepNet	61084_clinical_3	61084_clinical	61084_clinical_demographic	3														9																																											13387					21																													3	86.6									61084	1985-06-15
follow_up	ARDaC-AlcHepNet	61084_clinical_7	61084_clinical	61084_clinical_demographic	7												30.5		9																																											13390					18																													7	88.3									61084	1985-06-15
follow_up	ARDaC-AlcHepNet	61084_clinical_28	61084_clinical	61084_clinical_demographic	28												27.7		8																																											13409					13																0	0												28	80.3									61084	1985-06-15
follow_up	ARDaC-AlcHepNet	61084_clinical_60	61084_clinical	61084_clinical_demographic	60												26																																																		12																0	0												60	75.4									61084	1985-06-15
follow_up	ARDaC-AlcHepNet	61084_clinical_90	61084_clinical	61084_clinical_demographic	90																																																																														0	0												90										61084	1985-06-15
follow_up	ARDaC-AlcHepNet	61084_clinical_180	61084_clinical	61084_clinical_demographic	180																																																																														0	0												180										61084	1985-06-15
follow_up	ARDaC-AlcHepNet	71010_clinical_0	71010_clinical	71010_clinical_demographic	0												27.4		10							No																															No					14497					21																16	149												0	84.1									71010	1980-11-24
follow_up	ARDaC-AlcHepNet	71010_clinical_3	71010_clinical	71010_clinical_demographic	3												27.7		11							No																															No					14501					23																													3	85.1									71010	1980-11-24
follow_up	ARDaC-AlcHepNet	71010_clinical_7	71010_clinical	71010_clinical_demographic	7												28.1		9																																											14506					24																													7	86.8									71010	1980-11-24
follow_up	ARDaC-AlcHepNet	71010_clinical_14	71010_clinical	71010_clinical_demographic	14												28.3		10							No																															No					14513					25																0	0												14	87									71010	1980-11-24
follow_up	ARDaC-AlcHepNet	71010_clinical_28	71010_clinical	71010_clinical_demographic	28												23.8		10																																											14527					18																0	0												28	75.3									71010	1980-11-24
follow_up	ARDaC-AlcHepNet	71010_clinical_60	71010_clinical	71010_clinical_demographic	60												21.1		7																																											14564					14																0	0												60	65.2									71010	1980-11-24
follow_up	ARDaC-AlcHepNet	71010_clinical_90	71010_clinical	71010_clinical_demographic	90												23.6		7																																											14590					13																0	0												90	70.3									71010	1980-11-24
follow_up	ARDaC-AlcHepNet	71010_clinical_180	71010_clinical	71010_clinical_demographic	180												22.6		5																																											14681					8																0	0												180	68.5									71010	1980-11-24
follow_up	ARDaC-AlcHepNet	71011_clinical_0	71011_clinical	71011_clinical_demographic	0												24.7		11																																											14311					21																17	102												0	65.2									71011	1981-09-13
follow_up	ARDaC-AlcHepNet	71011_clinical_3	71011_clinical	71011_clinical_demographic	3												24.4		9																																											14313					21																													3	64.4									71011	1981-09-13
follow_up	ARDaC-AlcHepNet	71011_clinical_7	71011_clinical	71011_clinical_demographic	7												22.7		9																																											14318					20																													7	60.1									71011	1981-09-13
follow_up	ARDaC-AlcHepNet	71011_clinical_14	71011_clinical	71011_clinical_demographic	14												21.7		8																																											14325					19																4	82												14	58.8									71011	1981-09-13
follow_up	ARDaC-AlcHepNet	71011_clinical_28	71011_clinical	71011_clinical_demographic	28												22.6		8																																											14341					16																0	102												28	59.8									71011	1981-09-13
follow_up	ARDaC-AlcHepNet	71011_clinical_60	71011_clinical	71011_clinical_demographic	60												23		8																																											14376					17																1	1												60	60.9									71011	1981-09-13
follow_up	ARDaC-AlcHepNet	71011_clinical_180	71011_clinical	71011_clinical_demographic	180																																																									14487																																		180										71011	1981-09-13
follow_up	ARDaC-AlcHepNet	71012_clinical_0	71012_clinical	71012_clinical_demographic	0		Not Done							13123	Negative		26.6		10							No																														13124	Yes					13124					25																7	69						13124			Negative			0	77.1									71012	1985-02-22
follow_up	ARDaC-AlcHepNet	71012_clinical_3	71012_clinical	71012_clinical_demographic	3												26.5		8																																											13128					24																													3	76.9									71012	1985-02-22
follow_up	ARDaC-AlcHepNet	71012_clinical_7	71012_clinical	71012_clinical_demographic	7												26.2		8																																											13132					23																													7	75.8									71012	1985-02-22
follow_up	ARDaC-AlcHepNet	71012_clinical_14	71012_clinical	71012_clinical_demographic	14												26.5		8																																											13139					21																2	26												14	76.7									71012	1985-02-22
follow_up	ARDaC-AlcHepNet	71012_clinical_28	71012_clinical	71012_clinical_demographic	28												26.5		7																																											13152					16																0	0												28	76.7									71012	1985-02-22
follow_up	ARDaC-AlcHepNet	71012_clinical_60	71012_clinical	71012_clinical_demographic	60												26.3		6																																											13167					14																0	0												60	76.2									71012	1985-02-22
follow_up	ARDaC-AlcHepNet	71012_clinical_90	71012_clinical	71012_clinical_demographic	90												27.4		7																																											13214					14																3	10												90	79.3									71012	1985-02-22
follow_up	ARDaC-AlcHepNet	71012_clinical_180	71012_clinical	71012_clinical_demographic	180												28.9		6																																											13307					12																9	42												180	83.7									71012	1985-02-22
follow_up	ARDaC-AlcHepNet	71013_clinical_0	71013_clinical	71013_clinical_demographic	0			Negative	19326					19337	Negative		16.3		10							No																														19337	Yes					19340					23																8	224					Not Done							0	40.6									71013	1968-03-29
follow_up	ARDaC-AlcHepNet	71013_clinical_3	71013_clinical	71013_clinical_demographic	3														9																																											19343					24																													3	40.5									71013	1968-03-29
follow_up	ARDaC-AlcHepNet	71013_clinical_7	71013_clinical	71013_clinical_demographic	7												16.7		8																																											19348					19																													7	41.5									71013	1968-03-29
follow_up	ARDaC-AlcHepNet	71013_clinical_14	71013_clinical	71013_clinical_demographic	14												17.1		8																																											19355					18																													14	42.3									71013	1968-03-29
follow_up	ARDaC-AlcHepNet	71013_clinical_28	71013_clinical	71013_clinical_demographic	28												16		7																																											19369					12																0	0												28	39.6									71013	1968-03-29
follow_up	ARDaC-AlcHepNet	71013_clinical_60	71013_clinical	71013_clinical_demographic	60												16.5		5																																											19404					9																0	0												60	40.9									71013	1968-03-29
follow_up	ARDaC-AlcHepNet	71013_clinical_90	71013_clinical	71013_clinical_demographic	90												13.5		6																																											19481					16																30	159												90	33.5									71013	1968-03-29
follow_up	ARDaC-AlcHepNet	71013_clinical_180	71013_clinical	71013_clinical_demographic	180		Not Done							19522	Negative		17.3		10							Yes						No	Missing													No	Missing									19517	Yes					19523					24										Yes, Mild						24	159					Not Done							180	42.9									71013	1968-03-29
follow_up	ARDaC-AlcHepNet	71014_clinical_0	71014_clinical	71014_clinical_demographic	0		Not Done							17838	Negative		28.3		13							No																														17838	Yes					17839					31																20	1200						17838			Negative			0	100.1									71014	1972-05-09
follow_up	ARDaC-AlcHepNet	71014_clinical_3	71014_clinical	71014_clinical_demographic	3												27.6		14							No																															No					17842					30																													3	97.8									71014	1972-05-09
follow_up	ARDaC-AlcHepNet	71014_clinical_7	71014_clinical	71014_clinical_demographic	7												27.8		12																																											17845					26																													7	98.2									71014	1972-05-09
follow_up	ARDaC-AlcHepNet	71014_clinical_14	71014_clinical	71014_clinical_demographic	14												26.4		10																																											17856					28																0	0												14	93.2									71014	1972-05-09
follow_up	ARDaC-AlcHepNet	71014_clinical_28	71014_clinical	71014_clinical_demographic	28												24.5		10																																											17867					26																0	0												28	86.7									71014	1972-05-09
follow_up	ARDaC-AlcHepNet	71014_clinical_60	71014_clinical	71014_clinical_demographic	60												25.5		11																																											17900					18																8	31												60	90.2									71014	1972-05-09
follow_up	ARDaC-AlcHepNet	71014_clinical_90	71014_clinical	71014_clinical_demographic	90												23.6		8																																											17933					15																0	0												90	83.5									71014	1972-05-09
follow_up	ARDaC-AlcHepNet	71014_clinical_180	71014_clinical	71014_clinical_demographic	180		Not Done							18018	Negative		22.8		8							No																														18020	Yes					18020					14																24	345						18013			Negative			180	80.4									71014	1972-05-09
follow_up	ARDaC-AlcHepNet	71016_clinical_0	71016_clinical	71016_clinical_demographic	0		Not Done							22023	Negative		27.9		9							No																														22023	Yes					22024					31																24	180						22023			Negative			0	80.9									71016	1960-12-24
follow_up	ARDaC-AlcHepNet	71016_clinical_7	71016_clinical	71016_clinical_demographic	7												28.8		10																																											22031					30																													7	83.5									71016	1960-12-24
follow_up	ARDaC-AlcHepNet	71016_clinical_14	71016_clinical	71016_clinical_demographic	14			Negative	22039					22039	Negative		29.4		13							No																														22039	Yes					22038					37																							22040			Negative			14	85.1									71016	1960-12-24
follow_up	ARDaC-AlcHepNet	71018_clinical_0	71018_clinical	71018_clinical_demographic	0			Negative	16515					16514	Negative		44.8		11							No																														16514	Yes					16516					27																17	312						16514			Negative			0	137.5									71018	1976-03-02
follow_up	ARDaC-AlcHepNet	71018_clinical_3	71018_clinical	71018_clinical_demographic	3												43.7		11																																											16519					26																													3	138									71018	1976-03-02
follow_up	ARDaC-AlcHepNet	71018_clinical_7	71018_clinical	71018_clinical_demographic	7												43.8		11																																											16522					24																													7	138.5									71018	1976-03-02
follow_up	ARDaC-AlcHepNet	71018_clinical_14	71018_clinical	71018_clinical_demographic	14												43.5		10																																											16529					21																													14	137.4									71018	1976-03-02
follow_up	ARDaC-AlcHepNet	71018_clinical_28	71018_clinical	71018_clinical_demographic	28												20		9																																											16544					19																													28	63.2									71018	1976-03-02
follow_up	ARDaC-AlcHepNet	71018_clinical_60	71018_clinical	71018_clinical_demographic	60												40.9		8																																											16578					20																0	0												60	129.4									71018	1976-03-02
follow_up	ARDaC-AlcHepNet	71021_clinical_0	71021_clinical	71021_clinical_demographic	0												37		11																																											14154					24																28	105												0	120.4									71021	1982-12-01
follow_up	ARDaC-AlcHepNet	71021_clinical_3	71021_clinical	71021_clinical_demographic	3																																																									14157					23																													3										71021	1982-12-01
follow_up	ARDaC-AlcHepNet	71021_clinical_7	71021_clinical	71021_clinical_demographic	7												31.2		9																																											14161					20																													7	110.7									71021	1982-12-01
follow_up	ARDaC-AlcHepNet	71021_clinical_14	71021_clinical	71021_clinical_demographic	14												31.5		7																																											14167					16																													14	102.4									71021	1982-12-01
follow_up	ARDaC-AlcHepNet	71021_clinical_28	71021_clinical	71021_clinical_demographic	28												31.1		7																																											14182					12																0	0												28	101.2									71021	1982-12-01
follow_up	ARDaC-AlcHepNet	71021_clinical_60	71021_clinical	71021_clinical_demographic	60														5																																											14225					9																0	0												60										71021	1982-12-01
follow_up	ARDaC-AlcHepNet	71021_clinical_90	71021_clinical	71021_clinical_demographic	90												31.5		6																																											14253					8																0	0												90	102.557									71021	1982-12-01
follow_up	ARDaC-AlcHepNet	71021_clinical_180	71021_clinical	71021_clinical_demographic	180												32.1		7																																											14334					14																28	28												180	104.05									71021	1982-12-01
follow_up	ARDaC-AlcHepNet	71022_clinical_0	71022_clinical	71022_clinical_demographic	0		Not Done							19519	Negative				11							No																														19519	Yes					19521					23																24	200						19519			Negative			0	105.1									71022	1968-05-04
follow_up	ARDaC-AlcHepNet	71022_clinical_7	71022_clinical	71022_clinical_demographic	7												30		11																																											19528					26																													7	106.1									71022	1968-05-04
follow_up	ARDaC-AlcHepNet	71022_clinical_14	71022_clinical	71022_clinical_demographic	14												29.5		11																																											19535					25																													14	107									71022	1968-05-04
follow_up	ARDaC-AlcHepNet	71022_clinical_28	71022_clinical	71022_clinical_demographic	28												29.9		11																																											19553					24																0	0												28	108.65									71022	1968-05-04
follow_up	ARDaC-AlcHepNet	71022_clinical_60	71022_clinical	71022_clinical_demographic	60												30.5		11																																											19581					22																0	0												60	110.85									71022	1968-05-04
follow_up	ARDaC-AlcHepNet	71022_clinical_90	71022_clinical	71022_clinical_demographic	90												30.8		11							No																															No					19613					19																0	0												90	111.6									71022	1968-05-04
follow_up	ARDaC-AlcHepNet	71022_clinical_180	71022_clinical	71022_clinical_demographic	180												22.5		9																																											19728					19																0	0												180	81.55									71022	1968-05-04
follow_up	ARDaC-AlcHepNet	72009_clinical_0	72009_clinical	72009_clinical_demographic	0		Not Done							16885	Negative		20.5									No																														16885	Yes					16524					26																28	126						16885	Missing	Genitourinary flora isolated	Positive			0	63									72009	1975-05-09
follow_up	ARDaC-AlcHepNet	72009_clinical_3	72009_clinical	72009_clinical_demographic	3												20.1		8							No																															No					16527					22																													3	61.9									72009	1975-05-09
follow_up	ARDaC-AlcHepNet	72009_clinical_7	72009_clinical	72009_clinical_demographic	7												20.1		8																																											16532					20																													7	62.2									72009	1975-05-09
follow_up	ARDaC-AlcHepNet	72009_clinical_14	72009_clinical	72009_clinical_demographic	14												20.6		8							No																															No					16539					19																0	0												14	63.2									72009	1975-05-09
follow_up	ARDaC-AlcHepNet	72009_clinical_28	72009_clinical	72009_clinical_demographic	28												20.5		8							No																															No					16553					13																0	0												28	63									72009	1975-05-09
follow_up	ARDaC-AlcHepNet	72009_clinical_60	72009_clinical	72009_clinical_demographic	60												21		6																																											16590					12																0	0												60	64.6									72009	1975-05-09
follow_up	ARDaC-AlcHepNet	72009_clinical_90	72009_clinical	72009_clinical_demographic	90												21.7		5																																											16616					9																0	0												90	66.5									72009	1975-05-09
follow_up	ARDaC-AlcHepNet	72009_clinical_180	72009_clinical	72009_clinical_demographic	180												21.5		5																																											16713					8																2	4												180	66									72009	1975-05-09
follow_up	ARDaC-AlcHepNet	72012_clinical_0	72012_clinical	72012_clinical_demographic	0		Not Done							15144	Negative		29.7		10							Yes																														15144	Yes					15150					23										Yes, Moderate						15	120					Not Done							0	96.9									72012	1979-07-24
follow_up	ARDaC-AlcHepNet	72012_clinical_3	72012_clinical	72012_clinical_demographic	3												28.6		8																																											15155					20																													3	92.9									72012	1979-07-24
follow_up	ARDaC-AlcHepNet	72012_clinical_7	72012_clinical	72012_clinical_demographic	7												28.1		9																																											15158					19																													7	91.5									72012	1979-07-24
follow_up	ARDaC-AlcHepNet	72012_clinical_14	72012_clinical	72012_clinical_demographic	14												27.5		8																																											15165					19																4	138												14	89.4									72012	1979-07-24
follow_up	ARDaC-AlcHepNet	72012_clinical_28	72012_clinical	72012_clinical_demographic	28																																																									15200					25																													28										72012	1979-07-24
follow_up	ARDaC-AlcHepNet	72012_clinical_60	72012_clinical	72012_clinical_demographic	60												26.1																																																																		7	43												60	85									72012	1979-07-24
follow_up	ARDaC-AlcHepNet	72012_clinical_90	72012_clinical	72012_clinical_demographic	90												25		8																																											15248					14																1	2												90	79									72012	1979-07-24
follow_up	ARDaC-AlcHepNet	72012_clinical_180	72012_clinical	72012_clinical_demographic	180												24.5		6																																											15331					11																6	27												180	79.8									72012	1979-07-24
follow_up	ARDaC-AlcHepNet	72013_clinical_0	72013_clinical	72013_clinical_demographic	0			Negative	16751					16751	Negative		20.8		10							No																														16751	Yes					16751					30																25	211						16751			Negative			0	69.4									72013	1975-03-24
follow_up	ARDaC-AlcHepNet	72013_clinical_3	72013_clinical	72013_clinical_demographic	3												21.6		9																																											16755					27																													3	69.2									72013	1975-03-24
follow_up	ARDaC-AlcHepNet	72013_clinical_7	72013_clinical	72013_clinical_demographic	7												21.5		10																																											16759					26																													7	70.4									72013	1975-03-24
follow_up	ARDaC-AlcHepNet	72013_clinical_14	72013_clinical	72013_clinical_demographic	14												20.3		11																																											16772					24																													14	65.9									72013	1975-03-24
follow_up	ARDaC-AlcHepNet	72013_clinical_28	72013_clinical	72013_clinical_demographic	28												17.8		9																																											16779					23																1	1												28	58									72013	1975-03-24
follow_up	ARDaC-AlcHepNet	72013_clinical_60	72013_clinical	72013_clinical_demographic	60												20.7		12																																											16816					21																3	3												60	67.3									72013	1975-03-24
follow_up	ARDaC-AlcHepNet	72013_clinical_90	72013_clinical	72013_clinical_demographic	90												17.7		8																																											16844					18																2	4												90	58.4									72013	1975-03-24
follow_up	ARDaC-AlcHepNet	72013_clinical_180	72013_clinical	72013_clinical_demographic	180												20.8		8																																											16934					16																4	8												180	67.8									72013	1975-03-24
follow_up	ARDaC-AlcHepNet	72017_clinical_0	72017_clinical	72017_clinical_demographic	0		Not Done							15133	Negative		28.2		9							No																														15133	Yes					15136					23																27	127					Not Done							0	84									72017	1979-10-13
follow_up	ARDaC-AlcHepNet	72017_clinical_3	72017_clinical	72017_clinical_demographic	3												29.7		8																																											15143					20																													3	85.9									72017	1979-10-13
follow_up	ARDaC-AlcHepNet	72017_clinical_7	72017_clinical	72017_clinical_demographic	7												28.8		8																																											15143					19																													7	83.4									72017	1979-10-13
follow_up	ARDaC-AlcHepNet	72017_clinical_14	72017_clinical	72017_clinical_demographic	14												28.9		8																																											15152					16																													14	83.8									72017	1979-10-13
follow_up	ARDaC-AlcHepNet	72017_clinical_28	72017_clinical	72017_clinical_demographic	28												28.1		7																																											15164					13																													28	81.3									72017	1979-10-13
follow_up	ARDaC-AlcHepNet	72017_clinical_90	72017_clinical	72017_clinical_demographic	90												27.3		5																																											15217					8																2	34												90	86.3									72017	1979-10-13
follow_up	ARDaC-AlcHepNet	72017_clinical_180	72017_clinical	72017_clinical_demographic	180												60.3		5																																											15336					9																15	60												180	190.6									72017	1979-10-13
follow_up	ARDaC-AlcHepNet	72018_clinical_0	72018_clinical	72018_clinical_demographic	0			Negative	11734					11723	Negative		27.8		12							No																														11723	Yes					11735					25																							11723			Negative			0	87.7									72018	1989-02-05
follow_up	ARDaC-AlcHepNet	72018_clinical_7	72018_clinical	72018_clinical_demographic	7												28.2		11																																											11741					23																													7	89.2									72018	1989-02-05
follow_up	ARDaC-AlcHepNet	72018_clinical_14	72018_clinical	72018_clinical_demographic	14												27		10																																											11748					17																6	23												14	85.3									72018	1989-02-05
follow_up	ARDaC-AlcHepNet	72018_clinical_28	72018_clinical	72018_clinical_demographic	28												24.4		7																																											11762					13																0	0												28	77									72018	1989-02-05
follow_up	ARDaC-AlcHepNet	72018_clinical_60	72018_clinical	72018_clinical_demographic	60												24.8		5																																											11792					8																0	0												60	78.3									72018	1989-02-05
follow_up	ARDaC-AlcHepNet	72018_clinical_90	72018_clinical	72018_clinical_demographic	90												24.8		5																																											11828					7																0	6												90	78.5									72018	1989-02-05
follow_up	ARDaC-AlcHepNet	72018_clinical_180	72018_clinical	72018_clinical_demographic	180												25.6		5																																											11889					6																8	21												180	80.8									72018	1989-02-05
follow_up	ARDaC-AlcHepNet	72019_clinical_0	72019_clinical	72019_clinical_demographic	0			Negative	13094					13093	Negative		23.5		9							Yes				No	Small																									13094	Yes					13099					20										Yes, Mild													13093			Negative			0	70.2									72019	1985-05-13
follow_up	ARDaC-AlcHepNet	72019_clinical_90	72019_clinical	72019_clinical_demographic	90																																																									13239																																		90										72019	1985-05-13
follow_up	ARDaC-AlcHepNet	72019_clinical_180	72019_clinical	72019_clinical_demographic	180														7																																											13244					12																													180										72019	1985-05-13
follow_up	ARDaC-AlcHepNet	72020_clinical_0	72020_clinical	72020_clinical_demographic	0												26.4		12																																											13841					27																7	120												0	85.7									72020	1983-05-25
follow_up	ARDaC-AlcHepNet	72020_clinical_3	72020_clinical	72020_clinical_demographic	3												26.5		8																																											13844					24																													3	86.3									72020	1983-05-25
follow_up	ARDaC-AlcHepNet	72020_clinical_7	72020_clinical	72020_clinical_demographic	7												26.8		10																																											13848					21																													7	87.2									72020	1983-05-25
follow_up	ARDaC-AlcHepNet	72020_clinical_14	72020_clinical	72020_clinical_demographic	14												27.2		9																																											13855					20																													14	88.3									72020	1983-05-25
follow_up	ARDaC-AlcHepNet	72020_clinical_28	72020_clinical	72020_clinical_demographic	28												24.2		8																																											13869					19																													28	78.8									72020	1983-05-25
follow_up	ARDaC-AlcHepNet	72020_clinical_60	72020_clinical	72020_clinical_demographic	60												23.8		7																																											13902					18																0	0												60	77.5									72020	1983-05-25
follow_up	ARDaC-AlcHepNet	72020_clinical_90	72020_clinical	72020_clinical_demographic	90												24.4		7																																											13930					20																3	12												90	79.4									72020	1983-05-25
follow_up	ARDaC-AlcHepNet	72020_clinical_180	72020_clinical	72020_clinical_demographic	180												25.5		7																																											14020					18																0	0												180	82.8									72020	1983-05-25
follow_up	ARDaC-AlcHepNet	72021_clinical_0	72021_clinical	72021_clinical_demographic	0												24.8		9																																											15027					28																20	117												0	74									72021	1980-03-05
follow_up	ARDaC-AlcHepNet	72021_clinical_3	72021_clinical	72021_clinical_demographic	3																																																									15030					28																													3										72021	1980-03-05
follow_up	ARDaC-AlcHepNet	72021_clinical_7	72021_clinical	72021_clinical_demographic	7												25.4		12																																											15035					31																													7	75.5									72021	1980-03-05
follow_up	ARDaC-AlcHepNet	72021_clinical_14	72021_clinical	72021_clinical_demographic	14												25.3		12																																											15041					44																													14	74.8									72021	1980-03-05
follow_up	ARDaC-AlcHepNet	72022_clinical_0	72022_clinical	72022_clinical_demographic	0		Not Done							19710	Negative		35.7		10							No																														19710	Yes					19712					25																16	230						19710			Negative			0	112.7									72022	1967-05-15
follow_up	ARDaC-AlcHepNet	72022_clinical_3	72022_clinical	72022_clinical_demographic	3												35.7		10																																											19715					25																													3	113.2									72022	1967-05-15
follow_up	ARDaC-AlcHepNet	72022_clinical_7	72022_clinical	72022_clinical_demographic	7												38.9		9																																											19719					21																													7	123.1									72022	1967-05-15
follow_up	ARDaC-AlcHepNet	72022_clinical_14	72022_clinical	72022_clinical_demographic	14												39.1		9																																											19727					19																													14	123.6									72022	1967-05-15
follow_up	ARDaC-AlcHepNet	72022_clinical_28	72022_clinical	72022_clinical_demographic	28												35.7		8																																											19741					17																													28	112.7									72022	1967-05-15
follow_up	ARDaC-AlcHepNet	72022_clinical_60	72022_clinical	72022_clinical_demographic	60												35		8																																											19771					15																0	0												60	110.6									72022	1967-05-15
follow_up	ARDaC-AlcHepNet	72022_clinical_90	72022_clinical	72022_clinical_demographic	90												32.9		8																																											19832					14																0	1												90	104.1									72022	1967-05-15
follow_up	ARDaC-AlcHepNet	72022_clinical_180	72022_clinical	72022_clinical_demographic	180												37.3		8																																											19904					14																0	0												180	118									72022	1967-05-15
follow_up	ARDaC-AlcHepNet	72023_clinical_0	72023_clinical	72023_clinical_demographic	0												24.4		11																																											18971					26																28	268												0	74.8									72023	1969-05-26
follow_up	ARDaC-AlcHepNet	72023_clinical_7	72023_clinical	72023_clinical_demographic	7												24.4		10																																											18979					24																													7	74.9									72023	1969-05-26
follow_up	ARDaC-AlcHepNet	72023_clinical_14	72023_clinical	72023_clinical_demographic	14												22.6																																													18985					25																													14	69.3									72023	1969-05-26
follow_up	ARDaC-AlcHepNet	72023_clinical_28	72023_clinical	72023_clinical_demographic	28												22.2		9																																											19000					21																0	0												28	68.3									72023	1969-05-26
follow_up	ARDaC-AlcHepNet	72023_clinical_60	72023_clinical	72023_clinical_demographic	60												22.2		13																																											19029					32																0	0												60	68.3									72023	1969-05-26
follow_up	ARDaC-AlcHepNet	72023_clinical_90	72023_clinical	72023_clinical_demographic	90												14.4		10																																											19063					17																1	2												90	60.8									72023	1969-05-26
follow_up	ARDaC-AlcHepNet	72023_clinical_180	72023_clinical	72023_clinical_demographic	180												24.1		10																																											19152					12																0	2												180	74.1									72023	1969-05-26
follow_up	ARDaC-AlcHepNet	72029_clinical_0	72029_clinical	72029_clinical_demographic	0		Not Done							14391	Positive	1 of 2 bottles: staph hominis, likely contaminant	26.8		10							No																														14391	Yes					14394					28																27	102						14391			Negative			0	94.9									72029	1982-02-23
follow_up	ARDaC-AlcHepNet	72029_clinical_3	72029_clinical	72029_clinical_demographic	3																																																									14397					27																													3										72029	1982-02-23
follow_up	ARDaC-AlcHepNet	72029_clinical_7	72029_clinical	72029_clinical_demographic	7												26.2		8																																											14403					21																													7	92.5									72029	1982-02-23
follow_up	ARDaC-AlcHepNet	72029_clinical_14	72029_clinical	72029_clinical_demographic	14												25.8		8							No																															No					14408					21																													14	88.7									72029	1982-02-23
follow_up	ARDaC-AlcHepNet	72029_clinical_90	72029_clinical	72029_clinical_demographic	90												26.2		8																																											14476					12																3	20												90	92.7									72029	1982-02-23
follow_up	ARDaC-AlcHepNet	72029_clinical_180	72029_clinical	72029_clinical_demographic	180												29.3		10																																											14532					16																20	28												180	100.7									72029	1982-02-23
follow_up	ARDaC-AlcHepNet	72030_clinical_0	72030_clinical	72030_clinical_demographic	0		Not Done							16758	Negative		38.8		11							No																														16758	Yes					16763					23																							16758			Negative			0	126									72030	1975-09-03
follow_up	ARDaC-AlcHepNet	72030_clinical_3	72030_clinical	72030_clinical_demographic	3												38.1		8																																											16766					19																													3	123.8									72030	1975-09-03
follow_up	ARDaC-AlcHepNet	72030_clinical_7	72030_clinical	72030_clinical_demographic	7												37.6		8																																											16770					18																													7	122.2									72030	1975-09-03
follow_up	ARDaC-AlcHepNet	72030_clinical_14	72030_clinical	72030_clinical_demographic	14												37.3		8																																											16774					16																													14	121.1									72030	1975-09-03
follow_up	ARDaC-AlcHepNet	72030_clinical_28	72030_clinical	72030_clinical_demographic	28												37.1		7																																											16795					11																													28	120.5									72030	1975-09-03
follow_up	ARDaC-AlcHepNet	72030_clinical_60	72030_clinical	72030_clinical_demographic	60																																																									16815					15																													60										72030	1975-09-03
follow_up	ARDaC-AlcHepNet	72035_clinical_0	72035_clinical	72035_clinical_demographic	0												43.9		11																																											17797					30																													0	112.5									72035	1973-02-02
follow_up	ARDaC-AlcHepNet	72035_clinical_3	72035_clinical	72035_clinical_demographic	3												43.9		11																																											17799					24																													3	112.4									72035	1973-02-02
follow_up	ARDaC-AlcHepNet	72035_clinical_7	72035_clinical	72035_clinical_demographic	7												46.1		11																																											17805					26																													7	118.05									72035	1973-02-02
follow_up	ARDaC-AlcHepNet	72035_clinical_14	72035_clinical	72035_clinical_demographic	14												47.2		11																																											17811					26																													14	120.9									72035	1973-02-02
follow_up	ARDaC-AlcHepNet	72035_clinical_28	72035_clinical	72035_clinical_demographic	28												29.5		10																																											17825					28																0	0												28	109.86									72035	1973-02-02
follow_up	ARDaC-AlcHepNet	72035_clinical_60	72035_clinical	72035_clinical_demographic	60			Positive	17840		Aerobic Culture with Gram Klebsiella pneumoniae (A)			17840	Negative		39.43		11							No																														17840	Yes					17854					27																0	0					Not Done							60	97.8									72035	1973-02-02
follow_up	ARDaC-AlcHepNet	72035_clinical_90	72035_clinical	72035_clinical_demographic	90												31.3		8																																											17890					24																0	0												90	80.05									72035	1973-02-02
follow_up	ARDaC-AlcHepNet	72035_clinical_180	72035_clinical	72035_clinical_demographic	180												33.9		8																																											17974					21																0	0												180	86.9									72035	1973-02-02
follow_up	ARDaC-AlcHepNet	72036_clinical_0	72036_clinical	72036_clinical_demographic	0														13																																											11936					29																25	180												0										72036	1989-02-28
follow_up	ARDaC-AlcHepNet	72036_clinical_3	72036_clinical	72036_clinical_demographic	3																																																									11938					28																													3										72036	1989-02-28
follow_up	ARDaC-AlcHepNet	72036_clinical_7	72036_clinical	72036_clinical_demographic	7												32		12																																											11943					27																													7	84.5									72036	1989-02-28
follow_up	ARDaC-AlcHepNet	72036_clinical_14	72036_clinical	72036_clinical_demographic	14			Negative	11948				No				31.07		12							No																														11948	Yes					11950					31																							11948	No; Positive for other organisms only	Greater than 100,000 cfu/ml Escherichia Coli	Positive			14	82.2									72036	1989-02-28
follow_up	ARDaC-AlcHepNet	72036_clinical_28	72036_clinical	72036_clinical_demographic	28			Negative	11963					11963	Negative		28.87		12							No																														11962	Yes					11965					44																0	0						11962	No; Positive for other organisms only	60,000 cfu/mL Gram negative rodsAbnormal  Count below standard for ID and susceptibility.   Genitourinary flora isolated	Positive			28	76.3									72036	1989-02-28
follow_up	ARDaC-AlcHepNet	72038_clinical_0	72038_clinical	72038_clinical_demographic	0			Positive	19181		"Aerobic Culture with Gram	 Rare Staphylococcus aureus, Methicillin ResistantAbnormal"			19181	Negative				13							No																														19181	Yes					19183					28																16	300					Not Done							0	107.8									72038	1969-05-16
follow_up	ARDaC-AlcHepNet	72038_clinical_7	72038_clinical	72038_clinical_demographic	7												36.4		12																																											19191					25																													7	102.25									72038	1969-05-16
follow_up	ARDaC-AlcHepNet	72038_clinical_14	72038_clinical	72038_clinical_demographic	14												36.2		11																																											19199					24																													14	101.65									72038	1969-05-16
follow_up	ARDaC-AlcHepNet	72038_clinical_28	72038_clinical	72038_clinical_demographic	28												34.2		10																																											19213					21																0	0												28	96.05									72038	1969-05-16
follow_up	ARDaC-AlcHepNet	72038_clinical_60	72038_clinical	72038_clinical_demographic	60												31.3		9																																											19249					16																0	0												60	87.95									72038	1969-05-16
follow_up	ARDaC-AlcHepNet	72038_clinical_90	72038_clinical	72038_clinical_demographic	90												32.8		7																																											19275					14																0	0												90	92.25									72038	1969-05-16
follow_up	ARDaC-AlcHepNet	72038_clinical_180	72038_clinical	72038_clinical_demographic	180				19344					19344			34.1		5							Yes	19352					No	Small											No	Small											19344	No										13										Yes, Mild						0	0						19344						180	95.8									72038	1969-05-16
follow_up	ARDaC-AlcHepNet	72041_clinical_0	72041_clinical	72041_clinical_demographic	0		Not Done							20598	Negative		36.5		12							Yes																		No	Small											20598	Yes					20602					21										Yes, Moderate						12	0						20597			Negative			0	108.9									72041	1965-09-07
follow_up	ARDaC-AlcHepNet	72041_clinical_7	72041_clinical	72041_clinical_demographic	7												33.9		10																																											20609					17																													7	101.01									72041	1965-09-07
follow_up	ARDaC-AlcHepNet	72041_clinical_14	72041_clinical	72041_clinical_demographic	14												33.5		11																																											20616					15																													14	99.8									72041	1965-09-07
follow_up	ARDaC-AlcHepNet	72041_clinical_28	72041_clinical	72041_clinical_demographic	28																																																									20652					16																													28										72041	1965-09-07
follow_up	ARDaC-AlcHepNet	72041_clinical_90	72041_clinical	72041_clinical_demographic	90																																																									20713					12																													90										72041	1965-09-07
follow_up	ARDaC-AlcHepNet	81051_clinical_0	81051_clinical	81051_clinical_demographic	0														9																																											14935					22																23	138												0										81051	1979-12-13
follow_up	ARDaC-AlcHepNet	81051_clinical_3	81051_clinical	81051_clinical_demographic	3												36.9		9																																											14938					21																													3	130.6									81051	1979-12-13
follow_up	ARDaC-AlcHepNet	81051_clinical_7	81051_clinical	81051_clinical_demographic	7												35.3		8							No																															No					14942					18																													7	124.8									81051	1979-12-13
follow_up	ARDaC-AlcHepNet	81051_clinical_28	81051_clinical	81051_clinical_demographic	28												36.1		8							No																															No					14965					11																0	0												28	127.4									81051	1979-12-13
follow_up	ARDaC-AlcHepNet	81051_clinical_60	81051_clinical	81051_clinical_demographic	60																																																																														0	0												60										81051	1979-12-13
follow_up	ARDaC-AlcHepNet	81051_clinical_90	81051_clinical	81051_clinical_demographic	90												38		5							No																															No					15030					7																0	0												90	124.6									81051	1979-12-13
follow_up	ARDaC-AlcHepNet	81051_clinical_180	81051_clinical	81051_clinical_demographic	180																																																																														0	0												180										81051	1979-12-13
follow_up	ARDaC-AlcHepNet	81052_clinical_0	81052_clinical	81052_clinical_demographic	0												28.9		7																																											13874					23																													0	73.8									81052	1982-11-12
follow_up	ARDaC-AlcHepNet	81052_clinical_3	81052_clinical	81052_clinical_demographic	3												35.9		7																																											13877					22																													3	88.6									81052	1982-11-12
follow_up	ARDaC-AlcHepNet	81052_clinical_7	81052_clinical	81052_clinical_demographic	7												28.9		7																																											13880					22																													7	73.8									81052	1982-11-12
follow_up	ARDaC-AlcHepNet	81052_clinical_14	81052_clinical	81052_clinical_demographic	14												28.9		10																																											13887					20																11	30.5												14	73.8									81052	1982-11-12
follow_up	ARDaC-AlcHepNet	81052_clinical_28	81052_clinical	81052_clinical_demographic	28												28.7		5																																											13908					14																3	2.5												28	72									81052	1982-11-12
follow_up	ARDaC-AlcHepNet	81052_clinical_60	81052_clinical	81052_clinical_demographic	60																																																									13935					11																													60										81052	1982-11-12
follow_up	ARDaC-AlcHepNet	81053_clinical_0	81053_clinical	81053_clinical_demographic	0												20.4		8																																											10084					21																													0	55.7									81053	1993-04-03
follow_up	ARDaC-AlcHepNet	81053_clinical_7	81053_clinical	81053_clinical_demographic	7												34.1		8																																											10092					19																													7	60.1									81053	1993-04-03
follow_up	ARDaC-AlcHepNet	81053_clinical_28	81053_clinical	81053_clinical_demographic	28												20.3		7																																											10114					22																0	0												28	55.7									81053	1993-04-03
follow_up	ARDaC-AlcHepNet	81053_clinical_90	81053_clinical	81053_clinical_demographic	90		Not Done							10160	Negative		21.2		13							No																														10160	Yes					10167					30																						Not Done							90	58.1									81053	1993-04-03
follow_up	ARDaC-AlcHepNet	81053_clinical_180	81053_clinical	81053_clinical_demographic	180																																																									10237					26																													180										81053	1993-04-03
follow_up	ARDaC-AlcHepNet	81054_clinical_0	81054_clinical	81054_clinical_demographic	0												28		6																																											24255					20																													0	74.5									81054	1954-06-18
follow_up	ARDaC-AlcHepNet	81054_clinical_3	81054_clinical	81054_clinical_demographic	3												28		7																																											24258					18																													3	74.5									81054	1954-06-18
follow_up	ARDaC-AlcHepNet	81054_clinical_7	81054_clinical	81054_clinical_demographic	7												28.2		6																																											24261					17																													7	73.1									81054	1954-06-18
follow_up	ARDaC-AlcHepNet	81054_clinical_28	81054_clinical	81054_clinical_demographic	28												32.2		7																																											24286					16																0	0												28	84									81054	1954-06-18
follow_up	ARDaC-AlcHepNet	81054_clinical_90	81054_clinical	81054_clinical_demographic	90												29.7		6							No																															No					24339					9																0	0												90	78.9									81054	1954-06-18
follow_up	ARDaC-AlcHepNet	81054_clinical_180	81054_clinical	81054_clinical_demographic	180												31.5		6							No																															No					24434					18																													180	84.1									81054	1954-06-18
follow_up	ARDaC-AlcHepNet	81055_clinical_0	81055_clinical	81055_clinical_demographic	0												28.5		10																																											14609					26																16	272												0	90.2									81055	1980-12-10
follow_up	ARDaC-AlcHepNet	81055_clinical_3	81055_clinical	81055_clinical_demographic	3												28.5		9																																											14611					25																													3	90.2									81055	1980-12-10
follow_up	ARDaC-AlcHepNet	81055_clinical_7	81055_clinical	81055_clinical_demographic	7			Negative	14613				No				27.5		9							No																														14613	Yes					14614					26																						Not Done							7	87.1									81055	1980-12-10
follow_up	ARDaC-AlcHepNet	81055_clinical_60	81055_clinical	81055_clinical_demographic	60												25.1		8																																											14667					19																0	0												60	77.8									81055	1980-12-10
follow_up	ARDaC-AlcHepNet	81055_clinical_90	81055_clinical	81055_clinical_demographic	90																																																																														0	0												90										81055	1980-12-10
follow_up	ARDaC-AlcHepNet	81057_clinical_0	81057_clinical	81057_clinical_demographic	0												37.6		9																																											12102					29																													0	87.5									81057	1987-11-26
follow_up	ARDaC-AlcHepNet	81057_clinical_3	81057_clinical	81057_clinical_demographic	3												37.8		8																																											12104					28																													3	88									81057	1987-11-26
follow_up	ARDaC-AlcHepNet	81057_clinical_7	81057_clinical	81057_clinical_demographic	7												37.3		8																																											12108					26																													7	87.4									81057	1987-11-26
follow_up	ARDaC-AlcHepNet	81057_clinical_14	81057_clinical	81057_clinical_demographic	14																																																									12117					21																													14										81057	1987-11-26
follow_up	ARDaC-AlcHepNet	81057_clinical_28	81057_clinical	81057_clinical_demographic	28																																																									12134					18																													28										81057	1987-11-26
follow_up	ARDaC-AlcHepNet	81057_clinical_60	81057_clinical	81057_clinical_demographic	60		Not Done							12147	Negative				7							No																														12147	Yes					12154					15																0	0					Not Done							60										81057	1987-11-26
follow_up	ARDaC-AlcHepNet	81057_clinical_180	81057_clinical	81057_clinical_demographic	180																																																									12290																																		180										81057	1987-11-26
follow_up	ARDaC-AlcHepNet	81058_clinical_0	81058_clinical	81058_clinical_demographic	0												23.2		10																																											10655					26																													0	61.6									81058	1991-11-24
follow_up	ARDaC-AlcHepNet	81058_clinical_3	81058_clinical	81058_clinical_demographic	3												18.7		10																																											10658					27																													3	49.8									81058	1991-11-24
follow_up	ARDaC-AlcHepNet	81058_clinical_7	81058_clinical	81058_clinical_demographic	7		Not Done						No				23.4		8							No																														10662	Yes					10662					26																							10655	No; Positive for other organisms only	vancomycin resistant enterococcus	Positive			7	62.3									81058	1991-11-24
follow_up	ARDaC-AlcHepNet	81058_clinical_28	81058_clinical	81058_clinical_demographic	28																																																																														0	0												28										81058	1991-11-24
follow_up	ARDaC-AlcHepNet	81058_clinical_60	81058_clinical	81058_clinical_demographic	60												22.9		8							Yes						No	Small																								No					10713					24																0	0												60	54.3									81058	1991-11-24
follow_up	ARDaC-AlcHepNet	81058_clinical_90	81058_clinical	81058_clinical_demographic	90												23.1		10																																											10748					18																10	39												90	55.3									81058	1991-11-24
follow_up	ARDaC-AlcHepNet	81058_clinical_180	81058_clinical	81058_clinical_demographic	180												21.8		8																																											10840					14																2	10												180	52.1									81058	1991-11-24
follow_up	ARDaC-AlcHepNet	81061_clinical_0	81061_clinical	81061_clinical_demographic	0			Negative	15415					15415	Negative		25.4		12							No																														15415	Yes					15418					26																9	198						15415			Negative			0	67.2									81061	1978-12-08
follow_up	ARDaC-AlcHepNet	81061_clinical_3	81061_clinical	81061_clinical_demographic	3												25.1		13																																											15421					23																													3	66.4									81061	1978-12-08
follow_up	ARDaC-AlcHepNet	81061_clinical_7	81061_clinical	81061_clinical_demographic	7												24.7		12																																											15424					22																													7	65.5									81061	1978-12-08
follow_up	ARDaC-AlcHepNet	81061_clinical_14	81061_clinical	81061_clinical_demographic	14												20.7		10																																											15454					19																0	0												14	55									81061	1978-12-08
follow_up	ARDaC-AlcHepNet	81061_clinical_28	81061_clinical	81061_clinical_demographic	28												22		6																																											15448					11																0	0												28	58.1									81061	1978-12-08
follow_up	ARDaC-AlcHepNet	81061_clinical_60	81061_clinical	81061_clinical_demographic	60												22.5		9																																											15484					14																0	0												60	59.7									81061	1978-12-08
follow_up	ARDaC-AlcHepNet	81061_clinical_90	81061_clinical	81061_clinical_demographic	90																																																									15501																																		90										81061	1978-12-08
follow_up	ARDaC-AlcHepNet	81061_clinical_180	81061_clinical	81061_clinical_demographic	180												19.2		8							Yes	15567																														No					15603					18										Yes, Mild						6	6												180	52.7									81061	1978-12-08
follow_up	ARDaC-AlcHepNet	81063_clinical_0	81063_clinical	81063_clinical_demographic	0		Not Done							19588	Negative		30.5		9							No																														19588	Yes					19593					27																						Not Done							0	99.1									81063	1967-07-24
follow_up	ARDaC-AlcHepNet	81063_clinical_3	81063_clinical	81063_clinical_demographic	3												32.5		9																																											19596					23																													3	104.6									81063	1967-07-24
follow_up	ARDaC-AlcHepNet	81063_clinical_7	81063_clinical	81063_clinical_demographic	7												34.6		7																																											19601					23																													7	108.6									81063	1967-07-24
follow_up	ARDaC-AlcHepNet	81063_clinical_14	81063_clinical	81063_clinical_demographic	14												35.3		9																																											19608					22																0	0												14	113.4									81063	1967-07-24
follow_up	ARDaC-AlcHepNet	81063_clinical_28	81063_clinical	81063_clinical_demographic	28			Negative	19616					19616	Negative		33.2		12							No																														19616	Yes					19618					23																						Not Done							28	106.6									81063	1967-07-24
follow_up	ARDaC-AlcHepNet	81063_clinical_90	81063_clinical	81063_clinical_demographic	90												32.6																																																																		0	0												90	100.5									81063	1967-07-24
follow_up	ARDaC-AlcHepNet	81063_clinical_180	81063_clinical	81063_clinical_demographic	180												31.6		6																																											19778					13																													180	99.7									81063	1967-07-24
follow_up	ARDaC-AlcHepNet	81064_clinical_0	81064_clinical	81064_clinical_demographic	0												23.4		9							No																															No					20410					22																24	96												0	69.8									81064	1965-04-28
follow_up	ARDaC-AlcHepNet	81064_clinical_7	81064_clinical	81064_clinical_demographic	7												23.3		9																																											20417					20																													7	69.6									81064	1965-04-28
follow_up	ARDaC-AlcHepNet	81064_clinical_14	81064_clinical	81064_clinical_demographic	14												22.9		10																																											20424					20																0	0												14	68.4									81064	1965-04-28
follow_up	ARDaC-AlcHepNet	81064_clinical_28	81064_clinical	81064_clinical_demographic	28												22.3		9							No																															No					20438					18																0	0												28	66.5									81064	1965-04-28
follow_up	ARDaC-AlcHepNet	81064_clinical_60	81064_clinical	81064_clinical_demographic	60												22.2		9																																											20470					14																0	0												60	66.3									81064	1965-04-28
follow_up	ARDaC-AlcHepNet	81064_clinical_90	81064_clinical	81064_clinical_demographic	90												21.6		9																																											20498					14																4	3												90	64.4									81064	1965-04-28
follow_up	ARDaC-AlcHepNet	81064_clinical_180	81064_clinical	81064_clinical_demographic	180																																																									20596																																		180										81064	1965-04-28
follow_up	ARDaC-AlcHepNet	81068_clinical_0	81068_clinical	81068_clinical_demographic	0		Not Done							10606	Negative		28.7		10							No																														10606	Yes					10607					23																16	133					Not Done							0	82.9									81068	1992-04-06
follow_up	ARDaC-AlcHepNet	81068_clinical_3	81068_clinical	81068_clinical_demographic	3												28.7		10																																											10609					23																													3	82.9									81068	1992-04-06
follow_up	ARDaC-AlcHepNet	81068_clinical_7	81068_clinical	81068_clinical_demographic	7												27.9		10																																											10613					21																													7	80.6									81068	1992-04-06
follow_up	ARDaC-AlcHepNet	81068_clinical_14	81068_clinical	81068_clinical_demographic	14												27.6		10																																											10620					18																													14	81.1									81068	1992-04-06
follow_up	ARDaC-AlcHepNet	81068_clinical_28	81068_clinical	81068_clinical_demographic	28												31.6		9																																											10634					17																													28	91.4									81068	1992-04-06
follow_up	ARDaC-AlcHepNet	81070_clinical_0	81070_clinical	81070_clinical_demographic	0												31.2		12																																											11579					31																													0	92.2									81070	1989-08-17
follow_up	ARDaC-AlcHepNet	81070_clinical_3	81070_clinical	81070_clinical_demographic	3												32.7		12																																											11582					31																													3	96.6									81070	1989-08-17
follow_up	ARDaC-AlcHepNet	81070_clinical_7	81070_clinical	81070_clinical_demographic	7		Not Done							11581	Negative		31.2		13							No																														11581	Yes					11585					31																						Not Done							7	92.3									81070	1989-08-17
follow_up	ARDaC-AlcHepNet	81070_clinical_14	81070_clinical	81070_clinical_demographic	14		Not Done							11592	Negative		28.1		12							No																														11592	Yes					11592					25																						Not Done							14	85									81070	1989-08-17
follow_up	ARDaC-AlcHepNet	81070_clinical_28	81070_clinical	81070_clinical_demographic	28												27		11																																											11600					26																													28	81.8									81070	1989-08-17
follow_up	ARDaC-AlcHepNet	81070_clinical_60	81070_clinical	81070_clinical_demographic	60												28.1		9																																											11639					17																0	0												60	80.2									81070	1989-08-17
follow_up	ARDaC-AlcHepNet	81070_clinical_90	81070_clinical	81070_clinical_demographic	90																																																									11674																																		90										81070	1989-08-17
follow_up	ARDaC-AlcHepNet	81076_clinical_0	81076_clinical	81076_clinical_demographic	0			Negative	18991					18991	Negative		28.5		13							No																														18991	Yes					18994					21																10	60					Not Done							0	80.1									81076	1969-06-16
follow_up	ARDaC-AlcHepNet	81076_clinical_3	81076_clinical	81076_clinical_demographic	3			Negative	18997				No				27.2		13							No																														18997	Yes					18998					21																						Not Done							3	76.3									81076	1969-06-16
follow_up	ARDaC-AlcHepNet	81076_clinical_7	81076_clinical	81076_clinical_demographic	7												27.2		13							No																															No					19000					20																													7	76.3									81076	1969-06-16
follow_up	ARDaC-AlcHepNet	81076_clinical_14	81076_clinical	81076_clinical_demographic	14														11																																											19006					17																													14										81076	1969-06-16
follow_up	ARDaC-AlcHepNet	81076_clinical_28	81076_clinical	81076_clinical_demographic	28		Not Done							19016	Negative		23.6		8							No																														19016	Yes					19021					13																						Not Done							28	66.4									81076	1969-06-16
follow_up	ARDaC-AlcHepNet	81076_clinical_60	81076_clinical	81076_clinical_demographic	60												23.5		7																																											19055					11																0	0												60	65.4									81076	1969-06-16
follow_up	ARDaC-AlcHepNet	81076_clinical_90	81076_clinical	81076_clinical_demographic	90												25.5		6																																											19090					9																0	0												90	70.6									81076	1969-06-16
follow_up	ARDaC-AlcHepNet	81076_clinical_180	81076_clinical	81076_clinical_demographic	180		Not Done						No				28.7		7							Yes																														19176	Yes					19176					7																0	0					Not Done							180	79.5									81076	1969-06-16
follow_up	ARDaC-AlcHepNet	81077_clinical_0	81077_clinical	81077_clinical_demographic	0		Not Done							11644	Negative		25.7		10							No																														11647	Yes					11647					23																10	150					Not Done							0	88.3									81077	1989-08-04
follow_up	ARDaC-AlcHepNet	81077_clinical_3	81077_clinical	81077_clinical_demographic	3												27.1		11							No																															No					11649					25																													3	93.2									81077	1989-08-04
follow_up	ARDaC-AlcHepNet	81077_clinical_7	81077_clinical	81077_clinical_demographic	7												26.4		10																																											11652					26																													7	90.5									81077	1989-08-04
follow_up	ARDaC-AlcHepNet	81077_clinical_14	81077_clinical	81077_clinical_demographic	14														10																																											11660					25																													14										81077	1989-08-04
follow_up	ARDaC-AlcHepNet	81077_clinical_28	81077_clinical	81077_clinical_demographic	28												27.8		11							No																															No					11680					26																													28	97.1									81077	1989-08-04
follow_up	ARDaC-AlcHepNet	81077_clinical_60	81077_clinical	81077_clinical_demographic	60												26.3		13							No																															No					11701					26																0	0												60	89.8									81077	1989-08-04
follow_up	ARDaC-AlcHepNet	81077_clinical_90	81077_clinical	81077_clinical_demographic	90												23.5		8							No																															No					11737					18																0	0												90	81.3									81077	1989-08-04
follow_up	ARDaC-AlcHepNet	81077_clinical_180	81077_clinical	81077_clinical_demographic	180		Not Done						No				25.7		5							No																														11823	Yes					11823					14																0	0					Not Done							180	86.8									81077	1989-08-04
follow_up	ARDaC-AlcHepNet	81080_clinical_0	81080_clinical	81080_clinical_demographic	0		Not Done								Negative		29.7		8							No																														14541	Yes					14541					20																16	241					Not Done							0	93									81080	1981-09-16
follow_up	ARDaC-AlcHepNet	81080_clinical_3	81080_clinical	81080_clinical_demographic	3												26.2		8																																											14542					19																													3	82.1									81080	1981-09-16
follow_up	ARDaC-AlcHepNet	81080_clinical_7	81080_clinical	81080_clinical_demographic	7												29.4		8																																											14548					16																													7	92									81080	1981-09-16
follow_up	ARDaC-AlcHepNet	81080_clinical_14	81080_clinical	81080_clinical_demographic	14												26.2		9							No																															No					14555					14																													14	91									81080	1981-09-16
follow_up	ARDaC-AlcHepNet	81080_clinical_28	81080_clinical	81080_clinical_demographic	28												34.9		6							No																															No					14573					11																													28	94.7									81080	1981-09-16
follow_up	ARDaC-AlcHepNet	81080_clinical_60	81080_clinical	81080_clinical_demographic	60														5							Yes						No	Small																								No					14608					8																0	0												60										81080	1981-09-16
follow_up	ARDaC-AlcHepNet	81080_clinical_90	81080_clinical	81080_clinical_demographic	90												28.9		5							No																															No					14629					10																0	0												90	98.1									81080	1981-09-16
follow_up	ARDaC-AlcHepNet	81080_clinical_180	81080_clinical	81080_clinical_demographic	180		Not Done						No				31.2									No																														14727	Yes																										0	0					Not Done							180	106.6									81080	1981-09-16
follow_up	ARDaC-AlcHepNet	81091_clinical_0	81091_clinical	81091_clinical_demographic	0			Negative	20576					20578	Negative		32.9		10							No																														20578	Yes					20580					22																21	126						20578			Negative			0	104.1									81091	1965-04-28
follow_up	ARDaC-AlcHepNet	81091_clinical_3	81091_clinical	81091_clinical_demographic	3												33.5		9																																											20582					23																													3	104.1									81091	1965-04-28
follow_up	ARDaC-AlcHepNet	81091_clinical_7	81091_clinical	81091_clinical_demographic	7												32.9		9							No																															No					20587					25																													7	104.1									81091	1965-04-28
follow_up	ARDaC-AlcHepNet	81091_clinical_14	81091_clinical	81091_clinical_demographic	14									20593	Negative		33.2		9							Yes						Missing	Small											No	Large											20593	Yes					20592					30																													14	104.9									81091	1965-04-28
follow_up	ARDaC-AlcHepNet	81096_clinical_0	81096_clinical	81096_clinical_demographic	0		Not Done							15061	Negative		36.5		13							No																														15064	Yes					15064					28																0	0					Not Done							0	132.6									81096	1980-07-02
follow_up	ARDaC-AlcHepNet	81096_clinical_3	81096_clinical	81096_clinical_demographic	3												36.7		11																																											15066					23																													3	133.3									81096	1980-07-02
follow_up	ARDaC-AlcHepNet	81096_clinical_7	81096_clinical	81096_clinical_demographic	7												37.6		11							No																															No					15070					24																													7	132.3									81096	1980-07-02
follow_up	ARDaC-AlcHepNet	81096_clinical_14	81096_clinical	81096_clinical_demographic	14												35.5		10							No																															No					15079					22																													14	125.6									81096	1980-07-02
follow_up	ARDaC-AlcHepNet	81096_clinical_28	81096_clinical	81096_clinical_demographic	28														10							Yes						Missing	Small																								No					15086					20										Yes, Moderate						0	0												28										81096	1980-07-02
follow_up	ARDaC-AlcHepNet	81096_clinical_60	81096_clinical	81096_clinical_demographic	60		Not Done						No				35.1		8							No																														15129	Yes					15129					19																0	0					Not Done							60	122.7									81096	1980-07-02
follow_up	ARDaC-AlcHepNet	81096_clinical_90	81096_clinical	81096_clinical_demographic	90		Not Done						No				40.5		10							No																														15161	Yes					15161					19																0	0					Not Done							90	133.7									81096	1980-07-02
follow_up	ARDaC-AlcHepNet	81096_clinical_180	81096_clinical	81096_clinical_demographic	180		Not Done						No				37.6		8							No																														15246	Yes										19																0	0					Not Done							180	129.5									81096	1980-07-02
follow_up	ARDaC-AlcHepNet	81108_clinical_0	81108_clinical	81108_clinical_demographic	0		Not Done							13135	Negative		36.3		14							Yes	13009																													13137	Yes					13137					31										Yes, Unknown severity						8	64						13135			Negative			0	117.9									81108	1985-12-28
follow_up	ARDaC-AlcHepNet	81108_clinical_3	81108_clinical	81108_clinical_demographic	3		Not Done						No						14							No																														13139	Yes					13139					31																						Not Done							3										81108	1985-12-28
follow_up	ARDaC-AlcHepNet	81108_clinical_7	81108_clinical	81108_clinical_demographic	7		Not Done						No						13							No																														13143	Yes					13143					30																						Not Done							7										81108	1985-12-28
follow_up	ARDaC-AlcHepNet	81108_clinical_14	81108_clinical	81108_clinical_demographic	14																																																									13149																																		14										81108	1985-12-28
follow_up	ARDaC-AlcHepNet	81108_clinical_28	81108_clinical	81108_clinical_demographic	28			Negative	13156					13155	Positive	Staphylococcus Haemolyticus	31.2		13							Yes																														13158	Yes					13158					33										Yes, Mild						0	0					Not Done							28	101.5									81108	1985-12-28
follow_up	ARDaC-AlcHepNet	81108_clinical_60	81108_clinical	81108_clinical_demographic	60		Not Done							13177	Negative		36.1		13							No																														13191	Yes					13191					23																0	0					Not Done							60	107.3									81108	1985-12-28
follow_up	ARDaC-AlcHepNet	81108_clinical_90	81108_clinical	81108_clinical_demographic	90		Not Done						No				28.3		8							No																														13226	Yes					13226					22																1	3					Not Done							90	83.8									81108	1985-12-28
